data_1g6p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1g6p _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.439 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 10.1 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -164.29 145.63 8.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.995 0.903 . . . . 0.0 112.096 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . -141.66 -135.89 3.19 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 114.199 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 5.1 mttt -135.99 161.73 34.85 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 44' ' ' GLN . 14.1 t -121.88 135.7 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.785 0 CA-C-N 119.208 0.913 . . . . 0.0 108.71 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HD3' ' CD1' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -121.61 -28.5 4.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.422 2.326 . . . . 0.0 112.764 -177.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.42 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 70.6 m95 -156.85 134.65 10.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.842 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 25.9 t80 -121.08 126.21 49.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.198 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -132.27 174.19 10.48 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 62.56 146.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -65.94 -15.98 63.46 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.757 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 4.4 mptt -105.39 -137.27 0.36 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.619 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -100.62 72.91 0.42 Allowed Glycine 0 CA--C 1.525 0.664 0 C-N-CA 119.703 -1.237 . . . . 0.0 115.657 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 27' ' ' VAL . 13.3 t80 -113.07 153.54 28.0 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.34 -157.65 27.41 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 119.699 -1.238 . . . . 0.0 115.527 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -133.17 136.81 45.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.364 -0.918 . . . . 0.0 110.075 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.49 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -124.22 168.23 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 4' ' ' LYS . 63.7 m -125.08 123.48 39.84 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -69.19 141.99 54.39 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.577 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 19' ' ' LYS . 30.2 t0 -2.39 -91.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -116.16 29.93 7.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.675 0.274 . . . . 0.0 110.954 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.01 -111.07 3.36 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.967 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.431 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -132.61 -141.37 4.63 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.59 145.42 46.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.096 0.95 . . . . 0.0 112.933 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -114.28 -173.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.87 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.47 ' O ' HG11 ' A' ' 25' ' ' VAL . 12.5 m-85 -130.6 164.93 23.87 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.672 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 1.4 m -148.9 145.69 17.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 29' ' ' TRP . 2.7 t-160 -98.25 -47.48 5.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.619 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 27.0 p-90 146.16 -11.45 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.528 1.131 . . . . 0.0 109.73 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.417 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -113.13 25.64 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.057 0.848 . . . . 0.0 109.22 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.44 -0.952 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.842 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.973 0 CA-C-O 122.036 0.922 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -4.59 55.52 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.069 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.442 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER 76.29 -0.56 3.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.56 42.68 1.01 Allowed Glycine 0 N--CA 1.463 0.493 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.241 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.5 mt-30 -138.86 -162.01 1.26 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 117.382 0.591 . . . . 0.0 111.359 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 69.8 t -119.58 132.1 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 1.0 OUTLIER -113.96 172.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -116.29 96.77 5.7 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CE2' HG22 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -140.1 177.8 7.72 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.86 158.16 43.22 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.411 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.5 mm -138.66 142.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.131 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.598 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo . . . . . 0 N--CA 1.466 -0.132 0 CA-C-O 120.655 0.19 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.507 ' HA ' HG21 ' A' ' 25' ' ' VAL . 5.7 tt0 -129.76 153.64 48.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.329 0.585 . . . . 0.0 111.075 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.03 134.21 50.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.813 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.07 -30.22 7.06 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.482 0.658 . . . . 0.0 111.071 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 11.0 m-70 -129.39 117.75 21.09 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 31' ' ' ALA . 37.4 t -132.36 115.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 9.7 mtpt -118.97 -175.51 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.83 146.6 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.171 0.896 . . . . 0.0 113.068 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.53 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.4 m -152.1 175.04 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.655 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--N 1.309 -1.184 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.917 179.804 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.427 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 3.9 mmt . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -161.4 138.91 8.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.901 0.858 . . . . 0.0 111.092 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -140.06 -120.38 1.73 Allowed Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.561 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.6 ttmt -158.38 167.41 29.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.709 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.85 138.13 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.024 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -123.93 -32.58 3.25 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 126.684 2.49 . . . . 0.0 112.113 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 70.1 m95 -152.07 139.4 19.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.609 ' CG ' ' HB2' ' A' ' 40' ' ' LEU . 4.6 t80 -123.24 126.28 46.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.411 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.89 167.26 20.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 122.413 0.285 . . . . 0.0 110.323 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER 66.86 154.81 0.09 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.029 0.919 . . . . 0.0 111.522 178.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -66.35 -27.45 67.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.515 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 17.9 mmtt -94.5 -124.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.626 ' O ' ' HA ' ' A' ' 29' ' ' TRP . . . -114.85 77.06 0.26 Allowed Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.939 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 28' ' ' HIS . 1.5 t80 -109.93 156.48 20.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 118.942 1.371 . . . . 0.0 109.606 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.99 -148.82 20.75 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.595 -1.288 . . . . 0.0 115.712 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 25' ' ' VAL . 12.1 m-85 -133.21 143.38 49.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.011 -1.094 . . . . 0.0 109.418 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -129.79 155.91 41.73 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.894 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 4' ' ' LYS . 90.4 m -121.89 116.44 24.4 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.665 -0.647 . . . . 0.0 110.579 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.76 145.56 55.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.763 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -6.91 -92.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.784 1.233 . . . . 0.0 114.043 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.12 31.16 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.625 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.93 -108.93 3.13 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.78 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -134.85 -145.64 5.23 Favored Glycine 0 C--O 1.22 -0.724 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.69 161.86 18.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.433 0.635 . . . . 0.0 111.555 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -126.32 178.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 122.51 1.148 . . . . 0.0 111.54 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.436 ' O ' ' CG ' ' A' ' 58' ' ' GLN . 84.4 t80 -130.83 128.19 40.15 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 112.274 -2.239 . . . . 0.0 106.074 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -121.33 143.77 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.393 -176.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.456 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 1.6 t60 -92.02 -21.85 20.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.626 ' HA ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 103.67 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.132 0.878 . . . . 0.0 111.082 -176.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.89 17.91 11.79 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.901 1.375 . . . . 0.0 108.113 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.447 -0.592 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.793 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.609 ' HB2' ' CG ' ' A' ' 8' ' ' PHE . 3.4 mm? . . . . . 0 N--CA 1.413 -2.285 0 CA-C-O 122.39 1.09 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.14 -9.46 59.71 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.787 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 2.5 mp0 66.82 5.79 4.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.478 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.69 45.87 0.83 Allowed Glycine 0 CA--C 1.506 -0.508 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.011 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 3.3 mt-30 -141.49 -163.29 1.54 Allowed 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.492 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 76.7 t -118.52 132.59 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -114.23 176.11 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -175.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 35.4 tp10 -120.29 91.56 3.57 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -138.69 167.57 21.69 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -175.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -120.94 149.38 42.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.428 -1.715 . . . . 0.0 107.083 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -142.99 125.37 12.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.394 -178.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.729 179.9 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.463 -0.311 0 CA-C-O 120.635 0.181 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.53 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -128.65 152.22 48.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.794 0.806 . . . . 0.0 111.084 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.53 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.45 136.71 53.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.179 177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.43 -30.94 6.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.521 0.677 . . . . 0.0 111.209 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 3.6 m-70 -129.49 116.23 18.65 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 38.4 t -131.93 119.54 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.49 -177.72 4.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.11 141.99 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.986 0.812 . . . . 0.0 113.163 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.467 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 2.2 m -142.69 177.67 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.214 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.31 -1.143 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.957 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.427 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 89.7 mtm-85 -159.48 141.65 13.52 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 122.047 0.927 . . . . 0.0 113.21 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.16 -145.52 4.76 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.37 -1.287 . . . . 0.0 114.227 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -143.91 159.52 42.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG13 ' CD1' ' A' ' 40' ' ' LEU . 13.8 t -118.97 133.22 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.891 0 CA-C-N 119.514 1.052 . . . . 0.0 109.244 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -122.77 -26.25 4.51 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 126.001 2.063 . . . . 0.0 111.936 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 79.1 m95 -157.01 137.01 12.6 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.843 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 12.0 t80 -121.38 121.85 38.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.453 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.05 171.63 13.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 p 65.84 146.51 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.402 0.62 . . . . 0.0 109.886 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -64.92 -16.01 62.76 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 18.9 mttt -105.76 -126.59 0.24 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.607 ' CA ' ' HA ' ' A' ' 29' ' ' TRP . . . -111.0 74.5 0.21 Allowed Glycine 0 C--N 1.345 1.072 0 C-N-CA 119.22 -1.467 . . . . 0.0 116.356 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 35.5 t80 -113.87 159.73 19.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 118.434 1.117 . . . . 0.0 108.078 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.28 -152.66 24.49 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.764 -1.208 . . . . 0.0 115.199 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 13.8 m-85 -133.18 144.19 49.69 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -132.2 157.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.354 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 4' ' ' LYS . 77.5 m -121.8 119.01 30.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.694 0.679 . . . . 0.0 110.314 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -65.69 142.86 57.88 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.668 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 19' ' ' LYS . 44.1 t0 -4.63 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.649 1.18 . . . . 0.0 113.86 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -115.73 31.76 6.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.79 -106.88 3.08 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -134.72 -142.42 4.62 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 121.569 -0.348 . . . . 0.0 112.382 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -118.86 161.92 19.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.667 0.746 . . . . 0.0 111.868 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -129.67 -177.11 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.741 -179.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.503 ' CE2' ' CZ ' ' A' ' 16' ' ' PHE . 11.9 m-85 -129.3 155.99 44.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.897 -1.956 . . . . 0.0 106.423 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -148.34 138.97 17.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.462 ' CE1' ' CZ2' ' A' ' 29' ' ' TRP . 9.0 t-160 -92.19 -47.71 7.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' CA ' ' A' ' 13' ' ' GLY . 1.1 p90 142.78 -2.1 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.409 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 t -114.65 21.45 14.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 124.519 1.137 . . . . 0.0 109.2 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.843 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.422 -1.836 0 CA-C-O 121.343 0.592 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -5.18 55.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HA ' HG11 ' A' ' 5' ' ' VAL . 5.7 mt-10 82.17 -7.52 1.33 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.55 76.24 0.3 Allowed Glycine 0 N--CA 1.459 0.228 0 CA-C-O 119.482 -0.621 . . . . 0.0 112.926 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 27.5 pt20 -164.83 -162.07 0.61 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.327 1.063 . . . . 0.0 111.244 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 86.9 t -125.15 132.04 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -114.92 176.03 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.975 -175.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 17.5 tp10 -116.41 97.17 5.88 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -139.84 171.39 14.28 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -174.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.3 tm-20 -110.02 151.56 27.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.373 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.421 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -146.88 112.62 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.873 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.07 -179.722 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 CA-C-O 120.69 0.204 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.49 ' HA ' HG22 ' A' ' 25' ' ' VAL . 5.0 tt0 -130.23 156.83 43.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.471 0.653 . . . . 0.0 111.025 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -67.89 129.29 39.46 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.324 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.78 -33.23 6.81 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.675 0.75 . . . . 0.0 110.127 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.496 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 4.0 m-70 -130.06 117.66 20.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 31' ' ' ALA . 60.2 t -129.78 102.65 7.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 1.5 mttt -109.72 -172.54 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.05 146.65 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 45' ' ' VAL . 1.4 m -152.52 175.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.686 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.84 179.677 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.441 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 3.9 ttp . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -163.79 140.12 6.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.758 0.789 . . . . 0.0 112.108 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.426 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . -139.67 -134.47 3.13 Favored Glycine 0 C--O 1.22 -0.757 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.488 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 30.2 mttp -137.68 163.86 30.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' GLN . 12.8 t -123.81 134.77 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.93 -27.46 4.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 126.159 2.162 . . . . 0.0 112.377 -178.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 78.3 m95 -156.82 138.27 13.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.827 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 27.4 t80 -122.15 86.84 2.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' TYR . 3.3 t70 -89.5 166.38 13.72 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.854 -0.529 . . . . 0.0 110.049 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 1.2 t 64.1 145.03 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.685 0.755 . . . . 0.0 111.051 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -66.15 -16.37 63.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 27.3 mmtt -100.45 -140.31 0.33 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.622 ' CA ' ' HA ' ' A' ' 29' ' ' TRP . . . -98.93 70.26 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.112 -1.518 . . . . 0.0 115.274 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 t80 -113.86 148.29 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.06 -155.31 26.26 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 119.634 -1.27 . . . . 0.0 115.124 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 11.9 m-85 -132.83 139.48 47.5 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.322 -0.939 . . . . 0.0 109.437 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.25 148.78 31.03 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.417 -178.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.562 ' O ' ' N ' ' A' ' 4' ' ' LYS . 72.8 m -121.02 115.62 23.5 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.347 -0.846 . . . . 0.0 109.893 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -63.71 157.22 24.75 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.776 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -23.95 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 45.48 1.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.429 0.633 . . . . 0.0 111.092 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 -115.31 2.76 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.16 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' THR . . . -134.29 -146.94 5.52 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -116.05 158.57 22.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.513 0.673 . . . . 0.0 111.042 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -124.32 178.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 122.625 1.202 . . . . 0.0 111.815 -177.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.511 ' CE2' ' CZ ' ' A' ' 16' ' ' PHE . 9.1 m-85 -131.65 131.46 43.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.077 -2.328 . . . . 0.0 105.092 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 1.6 m -121.15 148.72 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 8.0 t-160 -95.8 -46.16 6.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.622 ' HA ' ' CA ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 139.69 -4.01 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 124.119 0.968 . . . . 0.0 111.048 -177.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.33 21.07 14.99 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 124.67 1.231 . . . . 0.0 109.292 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.524 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.827 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 122.202 1.001 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -81.46 -5.89 58.39 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.231 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER 77.87 -5.05 2.16 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.6 52.85 0.59 Allowed Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.897 -0.391 . . . . 0.0 112.669 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.2 mt-30 -143.52 -164.47 1.87 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.426 0.613 . . . . 0.0 110.937 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 79.5 t -119.62 131.12 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -114.17 171.97 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 3.4 tt0 -115.97 95.43 5.1 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -136.43 173.27 11.89 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -174.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -126.24 137.66 53.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.06 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -130.73 126.03 59.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.097 0.475 . . . . 0.0 112.035 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 C--O 1.233 0.235 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.028 -179.742 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' O ' HG22 ' A' ' 25' ' ' VAL . 94.4 Cg_endo . . . . . 0 N--CA 1.461 -0.387 0 N-CA-C 113.0 0.346 . . . . 0.0 113.0 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -130.95 158.72 39.49 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.514 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -67.81 126.86 30.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.324 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.57 -27.67 10.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.402 0.62 . . . . 0.0 111.536 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 1.5 m-70 -128.65 115.91 18.77 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 31' ' ' ALA . 51.3 t -126.97 109.54 20.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -113.96 -178.64 3.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.644 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.96 146.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.13 0.877 . . . . 0.0 112.941 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.5 m -152.12 175.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.311 -1.095 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.944 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 4.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -162.31 137.65 7.18 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.787 0.803 . . . . 0.0 111.732 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -139.85 -117.46 1.44 Allowed Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.183 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.7 mtmt -158.6 169.74 23.73 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.013 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -120.6 138.94 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.771 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 13.5 ptpt -122.98 -30.29 3.8 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 126.443 2.34 . . . . 0.0 112.16 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 63.0 m95 -152.02 128.38 10.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.589 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 35.8 t80 -115.48 120.63 40.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.805 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.87 174.26 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.41 ' CB ' ' CB ' ' A' ' 14' ' ' TYR . 7.6 t 64.6 147.18 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.54 0.686 . . . . 0.0 110.337 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -15.96 62.59 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.777 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -105.64 -140.66 0.37 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.519 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -100.46 80.15 0.46 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 15.9 t80 -117.49 154.25 31.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.7 -154.4 25.81 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 119.748 -1.215 . . . . 0.0 115.052 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -133.18 138.03 46.43 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.272 -0.964 . . . . 0.0 109.897 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -122.12 161.41 22.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.496 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 4' ' ' LYS . 91.5 m -125.39 118.95 27.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.124 0.874 . . . . 0.0 110.778 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' ASP . 5.9 ptpt -67.2 144.8 55.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.509 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' LYS . 15.4 t70 -5.76 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.819 1.248 . . . . 0.0 114.1 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.33 31.04 6.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.79 -109.54 3.18 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.769 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -134.36 -146.57 5.45 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 9.9 p-10 -119.21 150.3 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.828 0.823 . . . . 0.0 112.223 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.488 ' CG1' ' HB ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -114.9 -173.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.541 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.465 ' O ' HG11 ' A' ' 25' ' ' VAL . 6.0 m-85 -127.7 162.1 27.36 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.424 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.464 HG12 HG13 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -156.43 143.51 10.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -105.51 -47.65 3.87 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -174.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.519 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 46.3 p-90 165.68 -25.96 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.09 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 1.1 p -117.79 30.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 124.669 1.231 . . . . 0.0 107.916 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 59' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.694 0 CA-C-N 113.659 -1.609 . . . . 0.0 108.494 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.427 -1.585 0 CA-C-O 121.806 0.813 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.43 -12.79 59.52 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.501 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER 69.69 2.09 3.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.81 54.76 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.3 mt-30 -145.62 -164.47 1.96 Allowed 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 117.256 0.528 . . . . 0.0 110.405 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.671 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 79.2 t -118.52 128.12 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -113.55 171.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.07 93.39 4.16 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -135.92 170.85 15.34 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -123.41 136.58 54.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.236 0.349 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.852 -179.878 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo . . . . . 0 N--CA 1.461 -0.413 0 N-CA-C 111.362 -0.284 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -131.62 151.03 51.93 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.942 0.877 . . . . 0.0 112.327 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.532 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.93 151.13 46.94 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.541 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.0 -37.17 2.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.664 0.745 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.6 m-70 -129.13 115.35 17.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.412 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 69.6 t -128.83 135.66 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.0 112.039 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.5 -175.95 3.81 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.61 135.94 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.648 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.495 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 2.5 m -142.76 177.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.836 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.975 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.875 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 47.4 mtt180 -158.49 142.21 15.32 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.801 0.81 . . . . 0.0 113.133 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -140.72 -146.97 4.87 Favored Glycine 0 CA--C 1.497 -1.082 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.522 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 1.4 mttt -136.6 163.91 29.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 44' ' ' GLN . 17.3 t -119.28 133.49 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.755 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 4.0 pttt -121.86 -29.47 4.29 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 126.007 2.067 . . . . 0.0 112.997 -175.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.449 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 67.3 m95 -153.41 141.04 19.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 20.4 t80 -120.83 137.88 54.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.129 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 7.8 m-20 -134.22 120.9 20.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.421 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 1.8 m 60.11 154.61 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 122.05 0.929 . . . . 0.0 111.963 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -64.42 -29.76 70.82 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 14' ' ' TYR . 43.8 mmtt -75.13 94.72 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.597 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -17.16 74.45 0.0 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' LYS . 1.2 t80 -115.49 150.71 36.08 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.54 -160.07 28.57 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 119.437 -1.363 . . . . 0.0 115.075 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.14 129.55 38.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.009 -1.095 . . . . 0.0 110.11 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 0.7 OUTLIER -112.9 171.08 3.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.571 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 97.1 m -121.24 125.22 46.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 110.135 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -65.52 118.6 9.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t70 36.2 -88.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.796 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.3 pp20? -118.96 -36.47 3.41 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.74 -13.13 5.21 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.63 -174.95 48.44 Favored Glycine 0 C--N 1.323 -0.165 0 C-N-CA 119.577 -1.297 . . . . 0.0 112.763 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.7 m-20 -154.47 135.65 13.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.534 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -119.67 -177.75 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 122.407 1.099 . . . . 0.0 111.838 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.532 ' O ' HG13 ' A' ' 25' ' ' VAL . 17.1 m-85 -130.95 164.61 24.94 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.61 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.441 ' HA ' ' CG ' ' A' ' 58' ' ' GLN . 1.6 m -148.69 147.27 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.487 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -96.26 -57.09 2.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.597 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 170.25 -30.31 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.967 -0.458 . . . . 0.0 111.579 -178.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -118.23 29.78 7.59 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 124.936 1.397 . . . . 0.0 107.959 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.439 -0.995 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.302 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.519 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.429 -1.485 0 CA-C-O 121.787 0.803 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -93.01 -10.09 37.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.173 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER 75.16 -2.1 2.91 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.89 56.82 0.55 Allowed Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.126 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.536 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.1 mt-30 -143.94 -167.13 2.52 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 117.879 0.84 . . . . 0.0 111.105 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 85.0 t -122.18 129.63 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -114.21 175.65 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.082 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 1.9 mt-10 -117.28 96.83 5.6 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -143.98 173.39 11.76 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 117.63 2.455 . . . . 0.0 117.63 -175.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.4 148.79 41.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.515 HG23 HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -140.54 120.45 12.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.834 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 . . . . . 0 C--O 1.235 0.334 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.782 179.844 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo . . . . . 0 C--O 1.23 0.119 0 N-CA-C 111.562 -0.207 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 1.8 tt0 -132.73 151.63 51.93 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.859 0.838 . . . . 0.0 112.75 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.508 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -70.09 145.7 51.44 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 113.847 -1.524 . . . . 0.0 107.271 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.38 -34.16 3.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.515 0.674 . . . . 0.0 111.108 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.531 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 5.8 m-70 -129.04 113.14 14.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 31' ' ' ALA . 77.0 t -128.93 139.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.782 0.801 . . . . 0.0 112.454 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -135.9 -172.75 3.19 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.76 144.36 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.328 0.967 . . . . 0.0 113.193 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.494 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.4 m -151.67 174.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.466 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--N 1.31 -1.15 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.943 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 13.6 mmt . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 48.9 mtt85 -158.95 138.53 11.69 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.977 0.894 . . . . 0.0 113.123 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.32 -134.17 3.12 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 114.167 -1.378 . . . . 0.0 113.151 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.0 ttmm -159.33 167.53 28.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 42' ' ' GLU . 1.6 t -117.51 130.81 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.194 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.434 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 8.0 ptmt -123.48 -38.25 2.56 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 126.116 2.135 . . . . 0.0 112.726 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 78.3 m95 -141.44 135.45 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.566 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.584 ' CG ' ' HB2' ' A' ' 40' ' ' LEU . 14.8 t80 -120.43 133.8 55.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.306 0.574 . . . . 0.0 112.353 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 4.6 m-20 -133.76 136.37 44.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.233 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' CZ ' ' A' ' 8' ' ' PHE . 10.0 t 60.97 146.47 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.953 0.882 . . . . 0.0 111.905 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mppp? -66.66 -12.71 59.42 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.787 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' TYR . 2.8 mmtp -100.58 105.02 16.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -10.46 70.27 0.0 OUTLIER Glycine 0 CA--C 1.531 1.064 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.432 ' CD2' ' O ' ' A' ' 28' ' ' HIS . 0.4 OUTLIER -118.07 141.96 47.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 -147.87 17.51 Favored Glycine 0 CA--C 1.501 -0.828 0 C-N-CA 118.794 -1.669 . . . . 0.0 115.768 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 26' ' ' PHE . 3.9 m-85 -132.98 145.54 50.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.157 -1.021 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -130.88 159.11 43.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.103 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 4' ' ' LYS . 97.4 m -123.91 118.6 27.44 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.628 1.104 . . . . 0.0 111.643 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.14 130.08 41.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.764 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.5 t0 9.04 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.335 1.454 . . . . 0.0 113.997 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.38 24.89 11.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.47 0.176 . . . . 0.0 111.197 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.88 -107.41 2.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.487 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -133.63 -143.89 5.04 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -118.37 163.29 16.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.621 0.724 . . . . 0.0 111.853 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.531 ' CG1' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -127.24 -175.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.785 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.502 ' O ' HG13 ' A' ' 25' ' ' VAL . 55.6 m-85 -128.55 157.71 40.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.928 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 1.8 m -149.19 148.95 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.963 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -89.88 -61.3 1.72 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -174.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.596 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 17.8 p-90 169.32 -27.86 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 121.969 -0.457 . . . . 0.0 111.687 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.457 ' CB ' ' CE3' ' A' ' 29' ' ' TRP . 10.2 t -118.9 32.47 6.12 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.438 -1.035 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.331 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.584 ' HB2' ' CG ' ' A' ' 8' ' ' PHE . 2.1 mm? . . . . . 0 N--CA 1.414 -2.257 0 CA-C-O 122.328 1.061 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 1.4 mmtt -78.12 -6.49 54.89 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.48 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 15.9 pm0 53.93 15.28 0.82 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.348 0.659 . . . . 0.0 112.585 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.78 49.8 0.67 Allowed Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 7.0 mt-30 -144.4 -168.87 3.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 117.85 0.825 . . . . 0.0 111.663 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 74.8 t -120.67 130.15 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -113.93 176.49 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.583 -174.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 1.8 tt0 -117.7 96.62 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -145.26 167.87 21.79 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -175.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -121.24 146.13 47.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.089 -1.869 . . . . 0.0 106.372 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -140.24 136.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.719 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 N--CA 1.461 -0.433 0 N-CA-C 112.791 0.266 . . . . 0.0 112.791 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HA ' HG23 ' A' ' 25' ' ' VAL . 2.1 tt0 -130.5 152.49 49.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 111.083 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB3' ' CG2' ' A' ' 62' ' ' VAL . . . -69.54 138.46 53.29 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.013 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.95 -38.3 2.97 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.826 0.822 . . . . 0.0 109.792 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 17.7 m-70 -129.77 110.79 12.03 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 87.5 t -127.95 139.06 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.444 0.64 . . . . 0.0 111.666 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.414 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 4.3 mttp -134.46 -171.15 2.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.81 144.2 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.303 0.956 . . . . 0.0 113.175 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.5 m -151.36 175.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.491 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 . . . . . 0 C--N 1.309 -1.164 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.869 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 10.1 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -164.29 145.63 8.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.995 0.903 . . . . 0.0 112.096 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . -141.66 -135.89 3.19 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 114.199 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 5.1 mttt -135.99 161.73 34.85 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 44' ' ' GLN . 14.1 t -121.88 135.7 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.785 0 CA-C-N 119.208 0.913 . . . . 0.0 108.71 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HD3' ' CD1' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -121.61 -28.5 4.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.422 2.326 . . . . 0.0 112.764 -177.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.42 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 70.6 m95 -156.85 134.65 10.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.842 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 25.9 t80 -121.08 126.21 49.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.198 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -132.27 174.19 10.48 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 62.56 146.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -65.94 -15.98 63.46 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.757 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 4.4 mptt -105.39 -137.27 0.36 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.619 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -100.62 72.91 0.42 Allowed Glycine 0 CA--C 1.525 0.664 0 C-N-CA 119.703 -1.237 . . . . 0.0 115.657 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 27' ' ' VAL . 13.3 t80 -113.07 153.54 28.0 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.34 -157.65 27.41 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 119.699 -1.238 . . . . 0.0 115.527 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -133.17 136.81 45.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.364 -0.918 . . . . 0.0 110.075 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.49 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -124.22 168.23 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 4' ' ' LYS . 63.7 m -125.08 123.48 39.84 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -69.19 141.99 54.39 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.577 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 19' ' ' LYS . 30.2 t0 -2.39 -91.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -116.16 29.93 7.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.675 0.274 . . . . 0.0 110.954 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.01 -111.07 3.36 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.967 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -132.61 -141.37 4.63 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.59 145.42 46.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.096 0.95 . . . . 0.0 112.933 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -114.28 -173.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.87 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.47 ' O ' HG11 ' A' ' 25' ' ' VAL . 12.5 m-85 -130.6 164.93 23.87 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.672 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 32' ' ' ILE . 1.4 m -148.9 145.69 17.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 29' ' ' TRP . 2.7 t-160 -98.25 -47.48 5.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.619 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 27.0 p-90 146.16 -11.45 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.528 1.131 . . . . 0.0 109.73 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.417 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -113.13 25.64 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.057 0.848 . . . . 0.0 109.22 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -121.27 -29.8 4.42 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.532 ' HB ' ' CA ' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -114.8 61.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.661 0 CA-C-O 123.365 1.555 . . . . 0.0 108.173 176.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -124.34 84.01 2.22 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 111.989 -2.368 . . . . 0.0 110.643 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.3 175.63 6.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -122.91 21.05 9.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.746 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.89 -61.94 0.32 Allowed Glycine 0 C--N 1.33 0.25 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -164.29 94.56 0.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.065 0.46 . . . . 0.0 109.998 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -126.18 130.19 50.48 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.206 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.507 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -172.65 -32.53 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.842 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER 60.69 112.35 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.036 0.922 . . . . 0.0 110.702 -177.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -4.59 55.52 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.069 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER 76.29 -0.56 3.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.56 42.68 1.01 Allowed Glycine 0 N--CA 1.463 0.493 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.241 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.5 mt-30 -138.86 -162.01 1.26 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 117.382 0.591 . . . . 0.0 111.359 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 69.8 t -119.58 132.1 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 1.0 OUTLIER -113.96 172.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -116.29 96.77 5.7 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CE2' HG22 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -140.1 177.8 7.72 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.86 158.16 43.22 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.411 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.5 mm -138.66 142.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.131 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -131.03 133.58 45.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.598 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -117.18 130.5 56.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.77 -124.69 2.65 Favored Glycine 0 CA--C 1.508 -0.35 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.477 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -25.24 64.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.471 -0.364 . . . . 0.0 110.931 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -106.13 -127.36 0.25 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.197 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.75 166.48 12.16 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.452 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -70.74 127.14 13.43 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.527 2.152 . . . . 0.0 112.184 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.507 ' HA ' HG21 ' A' ' 25' ' ' VAL . 5.7 tt0 -129.76 153.64 48.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.329 0.585 . . . . 0.0 111.075 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.03 134.21 50.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.813 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.07 -30.22 7.06 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.482 0.658 . . . . 0.0 111.071 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 11.0 m-70 -129.39 117.75 21.09 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 31' ' ' ALA . 37.4 t -132.36 115.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 9.7 mtpt -118.97 -175.51 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.83 146.6 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.171 0.896 . . . . 0.0 113.068 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.53 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.4 m -152.1 175.04 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.655 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--N 1.309 -1.184 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.917 179.804 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 3.9 mmt . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -161.4 138.91 8.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.901 0.858 . . . . 0.0 111.092 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -140.06 -120.38 1.73 Allowed Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.561 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.6 ttmt -158.38 167.41 29.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.709 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.85 138.13 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.024 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 7' ' ' TRP . 0.1 OUTLIER -123.93 -32.58 3.25 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 126.684 2.49 . . . . 0.0 112.113 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 70.1 m95 -152.07 139.4 19.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.609 ' CG ' ' HB2' ' A' ' 40' ' ' LEU . 4.6 t80 -123.24 126.28 46.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.411 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.89 167.26 20.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 122.413 0.285 . . . . 0.0 110.323 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.432 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER 66.86 154.81 0.09 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.029 0.919 . . . . 0.0 111.522 178.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -66.35 -27.45 67.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.515 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 17.9 mmtt -94.5 -124.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.626 ' O ' ' HA ' ' A' ' 29' ' ' TRP . . . -114.85 77.06 0.26 Allowed Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.939 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.438 ' CD2' ' O ' ' A' ' 28' ' ' HIS . 1.5 t80 -109.93 156.48 20.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 118.942 1.371 . . . . 0.0 109.606 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.99 -148.82 20.75 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.595 -1.288 . . . . 0.0 115.712 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 25' ' ' VAL . 12.1 m-85 -133.21 143.38 49.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.011 -1.094 . . . . 0.0 109.418 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -129.79 155.91 41.73 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.894 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 4' ' ' LYS . 90.4 m -121.89 116.44 24.4 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.665 -0.647 . . . . 0.0 110.579 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.76 145.56 55.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.763 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -6.91 -92.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.784 1.233 . . . . 0.0 114.043 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.12 31.16 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.625 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.93 -108.93 3.13 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.78 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -134.85 -145.64 5.23 Favored Glycine 0 C--O 1.22 -0.724 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -117.69 161.86 18.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.433 0.635 . . . . 0.0 111.555 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -126.32 178.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 122.51 1.148 . . . . 0.0 111.54 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.436 ' O ' ' CG ' ' A' ' 58' ' ' GLN . 84.4 t80 -130.83 128.19 40.15 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 112.274 -2.239 . . . . 0.0 106.074 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -121.33 143.77 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.393 -176.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.456 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 1.6 t60 -92.02 -21.85 20.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.626 ' HA ' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 103.67 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.132 0.878 . . . . 0.0 111.082 -176.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.89 17.91 11.79 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.901 1.375 . . . . 0.0 108.113 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -123.66 -29.63 3.71 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.793 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.512 ' HB ' ' HA3' ' A' ' 13' ' ' GLY . 0.1 OUTLIER -115.53 59.21 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 123.497 1.618 . . . . 0.0 108.253 176.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -125.16 87.9 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 112.038 -2.346 . . . . 0.0 110.216 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.29 167.85 11.87 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.582 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -121.98 19.0 10.9 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.45 -60.24 0.32 Allowed Glycine 0 CA--C 1.508 -0.349 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -165.05 80.68 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.007 -0.597 . . . . 0.0 109.708 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HG2' HG23 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -115.28 123.37 48.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.455 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -162.91 164.06 26.04 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 122.581 1.182 . . . . 0.0 111.652 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.609 ' HB2' ' CG ' ' A' ' 8' ' ' PHE . 3.4 mm? -132.11 106.39 7.96 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 112.383 -2.19 . . . . 0.0 110.998 -175.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.14 -9.46 59.71 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.787 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 2.5 mp0 66.82 5.79 4.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.478 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.69 45.87 0.83 Allowed Glycine 0 CA--C 1.506 -0.508 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.011 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 3.3 mt-30 -141.49 -163.29 1.54 Allowed 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.492 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 76.7 t -118.52 132.59 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -114.23 176.11 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -175.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 35.4 tp10 -120.29 91.56 3.57 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -138.69 167.57 21.69 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -175.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -120.94 149.38 42.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.428 -1.715 . . . . 0.0 107.083 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -142.99 125.37 12.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.394 -178.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -130.54 167.1 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.729 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -112.87 129.34 56.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.8 -132.49 3.84 Favored Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -59.19 -28.22 66.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.958 0.409 . . . . 0.0 110.716 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -108.51 -124.91 0.25 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.045 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.08 -167.28 16.07 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.087 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -72.08 113.67 3.75 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.386 2.058 . . . . 0.0 112.005 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.53 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -128.65 152.22 48.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.794 0.806 . . . . 0.0 111.084 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.45 136.71 53.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.179 177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.43 -30.94 6.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.521 0.677 . . . . 0.0 111.209 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 3.6 m-70 -129.49 116.23 18.65 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 38.4 t -131.93 119.54 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.49 -177.72 4.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.11 141.99 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.986 0.812 . . . . 0.0 113.163 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.467 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 2.2 m -142.69 177.67 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.214 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.31 -1.143 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.957 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 89.7 mtm-85 -159.48 141.65 13.52 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 122.047 0.927 . . . . 0.0 113.21 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.16 -145.52 4.76 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.37 -1.287 . . . . 0.0 114.227 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -143.91 159.52 42.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG13 ' CD1' ' A' ' 40' ' ' LEU . 13.8 t -118.97 133.22 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.891 0 CA-C-N 119.514 1.052 . . . . 0.0 109.244 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -122.77 -26.25 4.51 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 126.001 2.063 . . . . 0.0 111.936 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 79.1 m95 -157.01 137.01 12.6 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.843 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 12.0 t80 -121.38 121.85 38.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.453 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.05 171.63 13.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 p 65.84 146.51 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.402 0.62 . . . . 0.0 109.886 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -64.92 -16.01 62.76 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 18.9 mttt -105.76 -126.59 0.24 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.609 ' HA3' ' HB ' ' A' ' 32' ' ' ILE . . . -111.0 74.5 0.21 Allowed Glycine 0 C--N 1.345 1.072 0 C-N-CA 119.22 -1.467 . . . . 0.0 116.356 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 35.5 t80 -113.87 159.73 19.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 118.434 1.117 . . . . 0.0 108.078 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.28 -152.66 24.49 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.764 -1.208 . . . . 0.0 115.199 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 13.8 m-85 -133.18 144.19 49.69 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -132.2 157.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.354 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 4' ' ' LYS . 77.5 m -121.8 119.01 30.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.694 0.679 . . . . 0.0 110.314 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -65.69 142.86 57.88 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.668 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 19' ' ' LYS . 44.1 t0 -4.63 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.649 1.18 . . . . 0.0 113.86 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -115.73 31.76 6.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.79 -106.88 3.08 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -134.72 -142.42 4.62 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 121.569 -0.348 . . . . 0.0 112.382 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -118.86 161.92 19.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.667 0.746 . . . . 0.0 111.868 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -129.67 -177.11 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.741 -179.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.503 ' CE2' ' CZ ' ' A' ' 16' ' ' PHE . 11.9 m-85 -129.3 155.99 44.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.897 -1.956 . . . . 0.0 106.423 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' ' 32' ' ' ILE . 0.5 OUTLIER -148.34 138.97 17.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.462 ' CE1' ' CZ2' ' A' ' 29' ' ' TRP . 9.0 t-160 -92.19 -47.71 7.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.607 ' HA ' ' CA ' ' A' ' 13' ' ' GLY . 1.1 p90 142.78 -2.1 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.409 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 t -114.65 21.45 14.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 124.519 1.137 . . . . 0.0 109.2 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -121.45 -25.0 5.26 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.609 ' HB ' ' HA3' ' A' ' 13' ' ' GLY . 0.8 OUTLIER -113.71 32.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-O 122.576 1.179 . . . . 0.0 109.776 177.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -119.61 93.5 4.09 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.163 -1.381 . . . . 0.0 112.666 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.452 ' HB2' ' CE ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -121.85 -170.51 2.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.245 178.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -120.18 28.52 8.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.123 0.487 . . . . 0.0 110.991 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.38 -100.41 2.19 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.39 78.12 0.36 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.223 0.535 . . . . 0.0 110.88 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' CD ' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -120.76 155.05 34.79 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.417 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -170.36 168.86 7.83 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.144 -176.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.843 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -120.93 114.18 21.18 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.155 -179.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -5.18 55.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HA ' HG11 ' A' ' 5' ' ' VAL . 5.7 mt-10 82.17 -7.52 1.33 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.55 76.24 0.3 Allowed Glycine 0 N--CA 1.459 0.228 0 CA-C-O 119.482 -0.621 . . . . 0.0 112.926 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 27.5 pt20 -164.83 -162.07 0.61 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.327 1.063 . . . . 0.0 111.244 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 86.9 t -125.15 132.04 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -114.92 176.03 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.975 -175.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 17.5 tp10 -116.41 97.17 5.88 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -139.84 171.39 14.28 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -174.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.3 tm-20 -110.02 151.56 27.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.373 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.421 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -146.88 112.62 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.873 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.61 136.04 49.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.07 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -109.94 153.16 24.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.105 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.16 -116.06 2.05 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.76 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -28.37 65.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.511 -0.344 . . . . 0.0 110.426 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.25 -114.34 0.31 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.85 -179.09 18.78 Favored Glycine 0 C--N 1.344 1.022 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.713 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.65 141.38 10.97 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.633 2.222 . . . . 0.0 112.526 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.49 ' HA ' HG22 ' A' ' 25' ' ' VAL . 5.0 tt0 -130.23 156.83 43.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.471 0.653 . . . . 0.0 111.025 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -67.89 129.29 39.46 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.324 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.78 -33.23 6.81 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.675 0.75 . . . . 0.0 110.127 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.496 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 4.0 m-70 -130.06 117.66 20.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 31' ' ' ALA . 60.2 t -129.78 102.65 7.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 47' ' ' GLU . 1.5 mttt -109.72 -172.54 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.05 146.65 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.477 ' O ' ' O ' ' A' ' 45' ' ' VAL . 1.4 m -152.52 175.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.686 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.84 179.677 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 3.9 ttp . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -163.79 140.12 6.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.758 0.789 . . . . 0.0 112.108 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.426 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . -139.67 -134.47 3.13 Favored Glycine 0 C--O 1.22 -0.757 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.488 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 30.2 mttp -137.68 163.86 30.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 44' ' ' GLN . 12.8 t -123.81 134.77 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.93 -27.46 4.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 126.159 2.162 . . . . 0.0 112.377 -178.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 78.3 m95 -156.82 138.27 13.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.827 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 27.4 t80 -122.15 86.84 2.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' TYR . 3.3 t70 -89.5 166.38 13.72 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.854 -0.529 . . . . 0.0 110.049 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 1.2 t 64.1 145.03 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.685 0.755 . . . . 0.0 111.051 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -66.15 -16.37 63.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 27.3 mmtt -100.45 -140.31 0.33 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.622 ' CA ' ' HA ' ' A' ' 29' ' ' TRP . . . -98.93 70.26 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.112 -1.518 . . . . 0.0 115.274 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 t80 -113.86 148.29 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.06 -155.31 26.26 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 119.634 -1.27 . . . . 0.0 115.124 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 11.9 m-85 -132.83 139.48 47.5 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.322 -0.939 . . . . 0.0 109.437 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.605 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.25 148.78 31.03 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.417 -178.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.562 ' O ' ' N ' ' A' ' 4' ' ' LYS . 72.8 m -121.02 115.62 23.5 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.347 -0.846 . . . . 0.0 109.893 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -63.71 157.22 24.75 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.776 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -23.95 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 45.48 1.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.429 0.633 . . . . 0.0 111.092 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 -115.31 2.76 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.16 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' THR . . . -134.29 -146.94 5.52 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -116.05 158.57 22.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.513 0.673 . . . . 0.0 111.042 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -124.32 178.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 122.625 1.202 . . . . 0.0 111.815 -177.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.511 ' CE2' ' CZ ' ' A' ' 16' ' ' PHE . 9.1 m-85 -131.65 131.46 43.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.077 -2.328 . . . . 0.0 105.092 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 1.6 m -121.15 148.72 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 8.0 t-160 -95.8 -46.16 6.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.622 ' HA ' ' CA ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 139.69 -4.01 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 124.119 0.968 . . . . 0.0 111.048 -177.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.33 21.07 14.99 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 124.67 1.231 . . . . 0.0 109.292 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.524 ' O ' ' HB ' ' A' ' 62' ' ' VAL . . . -121.64 -24.26 5.36 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.522 ' HB ' ' HA3' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -114.3 41.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.69 0 CA-C-O 122.841 1.305 . . . . 0.0 109.72 177.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.38 90.79 3.43 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.878 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.11 -175.58 3.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.07 23.03 10.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.961 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -117.23 -74.18 0.51 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -164.86 76.46 0.29 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.804 0.335 . . . . 0.0 110.851 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -116.05 111.09 19.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.549 0.69 . . . . 0.0 110.304 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.499 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -147.79 -24.07 0.37 Allowed 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.964 -176.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.827 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER 61.86 118.14 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.202 1.001 . . . . 0.0 110.741 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -81.46 -5.89 58.39 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.231 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER 77.87 -5.05 2.16 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.6 52.85 0.59 Allowed Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.897 -0.391 . . . . 0.0 112.669 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.2 mt-30 -143.52 -164.47 1.87 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.426 0.613 . . . . 0.0 110.937 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.588 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 79.5 t -119.62 131.12 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -114.17 171.97 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 3.4 tt0 -115.97 95.43 5.1 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -136.43 173.27 11.89 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -174.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -126.24 137.66 53.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.06 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -130.73 126.03 59.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.097 0.475 . . . . 0.0 112.035 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -129.63 140.75 51.08 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.028 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -112.41 163.15 14.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.609 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.02 -111.76 1.5 Allowed Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -81.92 -25.0 35.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.164 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -110.03 -125.18 0.27 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.541 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.26 166.82 13.98 Favored Glycine 0 C--N 1.344 0.996 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.411 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' O ' HG22 ' A' ' 25' ' ' VAL . 94.4 Cg_endo -85.15 147.12 10.19 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.446 2.097 . . . . 0.0 113.0 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -130.95 158.72 39.49 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.514 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -67.81 126.86 30.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.324 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.57 -27.67 10.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.402 0.62 . . . . 0.0 111.536 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 1.5 m-70 -128.65 115.91 18.77 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 31' ' ' ALA . 51.3 t -126.97 109.54 20.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 4.7 mttp -113.96 -178.64 3.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.644 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.96 146.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.13 0.877 . . . . 0.0 112.941 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.5 m -152.12 175.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.311 -1.095 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.944 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 4.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -162.31 137.65 7.18 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.787 0.803 . . . . 0.0 111.732 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' VAL . . . -139.85 -117.46 1.44 Allowed Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.183 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 14.7 mtmt -158.6 169.74 23.73 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.013 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -120.6 138.94 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.771 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 13.5 ptpt -122.98 -30.29 3.8 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 126.443 2.34 . . . . 0.0 112.16 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 63.0 m95 -152.02 128.38 10.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.589 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 35.8 t80 -115.48 120.63 40.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.805 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.87 174.26 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.41 ' CB ' ' CB ' ' A' ' 14' ' ' TYR . 7.6 t 64.6 147.18 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.54 0.686 . . . . 0.0 110.337 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -15.96 62.59 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.777 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -105.64 -140.66 0.37 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.519 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -100.46 80.15 0.46 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 15.9 t80 -117.49 154.25 31.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.7 -154.4 25.81 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 119.748 -1.215 . . . . 0.0 115.052 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -133.18 138.03 46.43 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.272 -0.964 . . . . 0.0 109.897 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.488 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -122.12 161.41 22.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.496 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 4' ' ' LYS . 91.5 m -125.39 118.95 27.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.124 0.874 . . . . 0.0 110.778 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' ASP . 5.9 ptpt -67.2 144.8 55.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.509 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' LYS . 15.4 t70 -5.76 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.819 1.248 . . . . 0.0 114.1 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.33 31.04 6.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.79 -109.54 3.18 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.769 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -134.36 -146.57 5.45 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 9.9 p-10 -119.21 150.3 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.828 0.823 . . . . 0.0 112.223 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.488 ' CG1' ' HB ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -114.9 -173.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.541 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.465 ' O ' HG11 ' A' ' 25' ' ' VAL . 6.0 m-85 -127.7 162.1 27.36 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.424 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG23 ' CD1' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -156.43 143.51 10.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.407 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -105.51 -47.65 3.87 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -174.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.519 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 46.3 p-90 165.68 -25.96 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.09 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 1.1 p -117.79 30.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 124.669 1.231 . . . . 0.0 107.916 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 59' ' ' ALA . . . -133.31 28.08 4.08 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 113.659 -1.609 . . . . 0.0 108.494 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.744 ' HA ' ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -121.68 -95.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 32' ' ' ILE . 2.6 tt0 -122.2 -75.37 0.6 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.17 -158.39 0.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -121.4 21.81 10.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.415 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.53 -83.97 1.05 Allowed Glycine 0 C--N 1.336 0.561 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.72 89.71 3.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.3 0.571 . . . . 0.0 109.677 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' O ' ' CG2' ' A' ' 39' ' ' THR . 0.0 OUTLIER -129.09 147.17 50.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -169.41 155.3 6.17 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -119.4 140.95 49.55 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.329 176.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.43 -12.79 59.52 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.501 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER 69.69 2.09 3.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.81 54.76 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.3 mt-30 -145.62 -164.47 1.96 Allowed 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 117.256 0.528 . . . . 0.0 110.405 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.671 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 79.2 t -118.52 128.12 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -113.55 171.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.07 93.39 4.16 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -135.92 170.85 15.34 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -123.41 136.58 54.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -119.89 119.52 33.76 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.852 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -118.51 66.3 0.77 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.99 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.77 -145.14 14.61 Favored Glycine 0 CA--C 1.508 -0.366 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.365 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -24.21 63.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.957 -0.621 . . . . 0.0 111.118 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -90.5 -123.52 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.426 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.91 154.79 16.56 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.081 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.63 98.15 0.98 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.488 2.125 . . . . 0.0 111.362 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -131.62 151.03 51.93 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.942 0.877 . . . . 0.0 112.327 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.532 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.93 151.13 46.94 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.541 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.0 -37.17 2.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.664 0.745 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.506 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.6 m-70 -129.13 115.35 17.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.744 ' HB ' ' HA ' ' A' ' 32' ' ' ILE . 69.6 t -128.83 135.66 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.0 112.039 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.5 -175.95 3.81 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.61 135.94 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.648 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.495 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 2.5 m -142.76 177.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.836 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.975 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.875 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 47.4 mtt180 -158.49 142.21 15.32 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.801 0.81 . . . . 0.0 113.133 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -140.72 -146.97 4.87 Favored Glycine 0 CA--C 1.497 -1.082 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.522 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 1.4 mttt -136.6 163.91 29.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 44' ' ' GLN . 17.3 t -119.28 133.49 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.755 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 4.0 pttt -121.86 -29.47 4.29 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 126.007 2.067 . . . . 0.0 112.997 -175.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.449 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 67.3 m95 -153.41 141.04 19.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.59 ' CZ ' ' HA ' ' A' ' 39' ' ' THR . 20.4 t80 -120.83 137.88 54.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.129 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 7.8 m-20 -134.22 120.9 20.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.421 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 1.8 m 60.11 154.61 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 122.05 0.929 . . . . 0.0 111.963 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -64.42 -29.76 70.82 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 14' ' ' TYR . 43.8 mmtt -75.13 94.72 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.597 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -17.16 74.45 0.0 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 12' ' ' LYS . 1.2 t80 -115.49 150.71 36.08 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.54 -160.07 28.57 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 119.437 -1.363 . . . . 0.0 115.075 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.14 129.55 38.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.009 -1.095 . . . . 0.0 110.11 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.547 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 0.7 OUTLIER -112.9 171.08 3.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.571 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' ASP . 97.1 m -121.24 125.22 46.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 110.135 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -65.52 118.6 9.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t70 36.2 -88.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.796 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.3 pp20? -118.96 -36.47 3.41 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.74 -13.13 5.21 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.63 -174.95 48.44 Favored Glycine 0 C--N 1.323 -0.165 0 C-N-CA 119.577 -1.297 . . . . 0.0 112.763 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.7 m-20 -154.47 135.65 13.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.534 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.547 ' CG1' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -119.67 -177.75 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 122.407 1.099 . . . . 0.0 111.838 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.532 ' O ' HG13 ' A' ' 25' ' ' VAL . 17.1 m-85 -130.95 164.61 24.94 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.61 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.523 HG21 ' CD1' ' A' ' 32' ' ' ILE . 1.6 m -148.69 147.27 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.487 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -96.26 -57.09 2.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.597 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 170.25 -30.31 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.967 -0.458 . . . . 0.0 111.579 -178.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -118.23 29.78 7.59 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 124.936 1.397 . . . . 0.0 107.959 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -130.44 31.59 4.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.302 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.609 HG23 HD21 ' A' ' 40' ' ' LEU . 1.2 mt -122.79 -57.81 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.056 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.445 ' CB ' ' CB ' ' A' ' 38' ' ' LYS . 4.8 tt0 -128.7 -66.73 0.82 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.017 0.913 . . . . 0.0 109.281 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -165.71 -134.62 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.597 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -120.12 28.56 7.99 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.723 -0.611 . . . . 0.0 110.027 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.52 -120.12 3.17 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.604 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.5 120.85 35.07 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.423 0.63 . . . . 0.0 109.908 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' CB ' ' CB ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -145.83 176.65 9.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.694 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE . 0.6 OUTLIER -171.16 161.14 6.6 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.693 0.759 . . . . 0.0 113.035 177.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.609 HD21 HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -117.8 158.13 25.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.383 177.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -93.01 -10.09 37.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.173 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER 75.16 -2.1 2.91 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.89 56.82 0.55 Allowed Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.126 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.536 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.1 mt-30 -143.94 -167.13 2.52 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 117.879 0.84 . . . . 0.0 111.105 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 85.0 t -122.18 129.63 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -114.21 175.65 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.082 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 1.9 mt-10 -117.28 96.83 5.6 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -143.98 173.39 11.76 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 117.63 2.455 . . . . 0.0 117.63 -175.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.4 148.79 41.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.515 HG23 HD11 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -140.54 120.45 12.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.834 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -101.3 106.6 17.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.59 61.05 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.11 -132.16 6.25 Favored Glycine 0 CA--C 1.509 -0.296 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.162 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -15.69 58.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.761 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -100.09 -129.18 0.21 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.11 131.74 9.62 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.12 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.7 88.26 0.1 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.066 1.844 . . . . 0.0 111.562 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.508 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 1.8 tt0 -132.73 151.63 51.93 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.859 0.838 . . . . 0.0 112.75 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.508 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -70.09 145.7 51.44 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 113.847 -1.524 . . . . 0.0 107.271 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.38 -34.16 3.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.515 0.674 . . . . 0.0 111.108 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.531 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 5.8 m-70 -129.04 113.14 14.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.46 ' HB ' ' CA ' ' A' ' 32' ' ' ILE . 77.0 t -128.93 139.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.782 0.801 . . . . 0.0 112.454 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -135.9 -172.75 3.19 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.76 144.36 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.328 0.967 . . . . 0.0 113.193 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.494 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.4 m -151.67 174.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.466 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--N 1.31 -1.15 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.943 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 13.6 mmt . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 48.9 mtt85 -158.95 138.53 11.69 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.977 0.894 . . . . 0.0 113.123 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.32 -134.17 3.12 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 114.167 -1.378 . . . . 0.0 113.151 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 2.0 ttmm -159.33 167.53 28.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' CG1' ' HA ' ' A' ' 42' ' ' GLU . 1.6 t -117.51 130.81 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.194 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.434 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 8.0 ptmt -123.48 -38.25 2.56 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 126.116 2.135 . . . . 0.0 112.726 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 78.3 m95 -141.44 135.45 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.566 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.584 ' CG ' ' HB2' ' A' ' 40' ' ' LEU . 14.8 t80 -120.43 133.8 55.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.306 0.574 . . . . 0.0 112.353 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 4.6 m-20 -133.76 136.37 44.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.233 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' CZ ' ' A' ' 8' ' ' PHE . 10.0 t 60.97 146.47 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.953 0.882 . . . . 0.0 111.905 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mppp? -66.66 -12.71 59.42 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.787 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 14' ' ' TYR . 2.8 mmtp -100.58 105.02 16.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -10.46 70.27 0.0 OUTLIER Glycine 0 CA--C 1.531 1.064 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' CD2' ' O ' ' A' ' 28' ' ' HIS . 0.4 OUTLIER -118.07 141.96 47.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 -147.87 17.51 Favored Glycine 0 CA--C 1.501 -0.828 0 C-N-CA 118.794 -1.669 . . . . 0.0 115.768 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 26' ' ' PHE . 3.9 m-85 -132.98 145.54 50.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.157 -1.021 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HB ' ' CG1' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -130.88 159.11 43.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.103 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 4' ' ' LYS . 97.4 m -123.91 118.6 27.44 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.628 1.104 . . . . 0.0 111.643 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.14 130.08 41.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.764 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.5 t0 9.04 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.335 1.454 . . . . 0.0 113.997 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.38 24.89 11.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.47 0.176 . . . . 0.0 111.197 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.88 -107.41 2.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.487 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 18' ' ' THR . . . -133.63 -143.89 5.04 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -118.37 163.29 16.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.621 0.724 . . . . 0.0 111.853 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.531 ' CG1' ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -127.24 -175.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.785 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.502 ' O ' HG13 ' A' ' 25' ' ' VAL . 55.6 m-85 -128.55 157.71 40.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.928 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 32' ' ' ILE . 1.8 m -149.19 148.95 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.963 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -89.88 -61.3 1.72 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -174.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.596 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 17.8 p-90 169.32 -27.86 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 121.969 -0.457 . . . . 0.0 111.687 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.457 ' CB ' ' CE3' ' A' ' 29' ' ' TRP . 10.2 t -118.9 32.47 6.12 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' O ' ' CG2' ' A' ' 62' ' ' VAL . . . -135.79 35.75 2.87 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.331 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.763 HD13 HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -123.11 -62.21 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.43 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -131.68 -57.18 1.0 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.229 0.538 . . . . 0.0 110.665 177.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -167.56 -147.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.874 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -120.33 27.86 8.36 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.67 -86.57 0.64 Allowed Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.191 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -123.89 107.13 11.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.757 0.313 . . . . 0.0 110.521 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -127.53 136.86 52.31 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.003 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.473 ' C ' ' CD2' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.58 152.23 49.19 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-O 122.951 1.357 . . . . 0.0 113.464 177.868 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.763 HD23 HD13 ' A' ' 32' ' ' ILE . 2.1 mm? -128.26 111.47 13.43 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 111.47 -2.604 . . . . 0.0 111.175 -173.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 1.4 mmtt -78.12 -6.49 54.89 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.48 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 15.9 pm0 53.93 15.28 0.82 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.348 0.659 . . . . 0.0 112.585 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.78 49.8 0.67 Allowed Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 7.0 mt-30 -144.4 -168.87 3.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 117.85 0.825 . . . . 0.0 111.663 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.595 ' HA ' ' HA ' ' A' ' 4' ' ' LYS . 74.8 t -120.67 130.15 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 2' ' ' ARG . 0.9 OUTLIER -113.93 176.49 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.583 -174.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 1.8 tt0 -117.7 96.62 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -145.26 167.87 21.79 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -175.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -121.24 146.13 47.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.089 -1.869 . . . . 0.0 106.372 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -140.24 136.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -130.33 143.75 50.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.719 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -117.05 144.86 44.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.119 0.485 . . . . 0.0 111.439 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.38 97.83 0.39 Allowed Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.35 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 tptt 69.86 -62.83 0.41 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.277 -0.461 . . . . 0.0 110.822 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -78.68 -112.11 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.19 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.36 173.77 14.93 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.232 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -88.19 147.53 6.56 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.924 2.416 . . . . 0.0 112.791 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.505 ' HA ' HG23 ' A' ' 25' ' ' VAL . 2.1 tt0 -130.5 152.49 49.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 111.083 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.488 ' HB3' ' CG2' ' A' ' 62' ' ' VAL . . . -69.54 138.46 53.29 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.013 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.95 -38.3 2.97 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.826 0.822 . . . . 0.0 109.792 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 17.7 m-70 -129.77 110.79 12.03 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' A' ' 59' ' ' ALA . 87.5 t -127.95 139.06 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.444 0.64 . . . . 0.0 111.666 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.414 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 4.3 mttp -134.46 -171.15 2.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.81 144.2 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.303 0.956 . . . . 0.0 113.175 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.5 m -151.36 175.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.491 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 . . . . . 0 C--N 1.309 -1.164 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.869 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 10.1 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -164.29 145.63 8.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.995 0.903 . . . . 0.0 112.096 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.855 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -141.66 -135.89 3.19 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 114.199 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 5.1 mttt -135.99 161.73 34.85 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 42' ' ' GLU . 14.1 t -121.88 135.7 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.785 0 CA-C-N 119.208 0.913 . . . . 0.0 108.71 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.61 -28.5 4.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.422 2.326 . . . . 0.0 112.764 -177.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.43 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 70.6 m95 -156.85 134.65 10.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.892 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 25.9 t80 -121.08 126.21 49.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.198 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -132.27 174.19 10.48 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 62.56 146.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -65.94 -15.98 63.46 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.757 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 4.4 mptt -105.39 -137.27 0.36 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.692 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -100.62 72.91 0.42 Allowed Glycine 0 CA--C 1.525 0.664 0 C-N-CA 119.703 -1.237 . . . . 0.0 115.657 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 27' ' ' VAL . 13.3 t80 -113.07 153.54 28.0 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.34 -157.65 27.41 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 119.699 -1.238 . . . . 0.0 115.527 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -133.17 136.81 45.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.364 -0.918 . . . . 0.0 110.075 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.822 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -124.22 168.23 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.832 HG23 ' O ' ' A' ' 23' ' ' GLY . 63.7 m -125.08 123.48 39.84 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -69.19 141.99 54.39 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.577 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 19' ' ' LYS . 30.2 t0 -2.39 -91.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -116.16 29.93 7.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.675 0.274 . . . . 0.0 110.954 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.01 -111.07 3.36 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.967 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.832 ' O ' HG23 ' A' ' 18' ' ' THR . . . -132.61 -141.37 4.63 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 3.3 p30 -119.59 145.42 46.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.096 0.95 . . . . 0.0 112.933 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.083 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -114.28 -173.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.87 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.613 ' N ' HG13 ' A' ' 25' ' ' VAL . 12.5 m-85 -130.6 164.93 23.87 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.672 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 13' ' ' GLY . 1.4 m -148.9 145.69 17.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 29' ' ' TRP . 2.7 t-160 -98.25 -47.48 5.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.681 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 27.0 p-90 146.16 -11.45 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.528 1.131 . . . . 0.0 109.73 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -113.13 25.64 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.057 0.848 . . . . 0.0 109.22 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.44 -0.952 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.892 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.973 0 CA-C-O 122.036 0.922 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HE3' HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -80.95 -4.59 55.52 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.069 178.251 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.785 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER 76.29 -0.56 3.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.56 42.68 1.01 Allowed Glycine 0 N--CA 1.463 0.493 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.241 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.5 mt-30 -138.86 -162.01 1.26 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 117.382 0.591 . . . . 0.0 111.359 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.924 HG12 ' CG2' ' A' ' 65' ' ' VAL . 69.8 t -119.58 132.1 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -113.96 172.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -116.29 96.77 5.7 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -140.1 177.8 7.72 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.86 158.16 43.22 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.411 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.083 HD12 HG21 ' A' ' 25' ' ' VAL . 5.5 mm -138.66 142.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.131 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.598 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 25' ' ' VAL . 11.0 Cg_exo . . . . . 0 N--CA 1.466 -0.132 0 CA-C-O 120.655 0.19 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 5.7 tt0 -129.76 153.64 48.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.329 0.585 . . . . 0.0 111.075 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.894 ' HA ' HD13 ' A' ' 50' ' ' ILE . . . -68.03 134.21 50.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.813 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.07 -30.22 7.06 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.482 0.658 . . . . 0.0 111.071 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 11.0 m-70 -129.39 117.75 21.09 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.557 HG23 ' HB1' ' A' ' 31' ' ' ALA . 37.4 t -132.36 115.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.834 ' O ' HG22 ' A' ' 46' ' ' VAL . 9.7 mtpt -118.97 -175.51 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.531 HG21 ' HE3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -120.83 146.6 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.171 0.896 . . . . 0.0 113.068 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.924 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -152.1 175.04 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.655 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--N 1.309 -1.184 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.917 179.804 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.9 mmt . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HD2' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -161.4 138.91 8.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.901 0.858 . . . . 0.0 111.092 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.653 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -140.06 -120.38 1.73 Allowed Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.561 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.6 ttmt -158.38 167.41 29.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.709 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.855 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -120.85 138.13 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.024 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -123.93 -32.58 3.25 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 126.684 2.49 . . . . 0.0 112.113 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 70.1 m95 -152.07 139.4 19.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.78 ' CE1' HD23 ' A' ' 40' ' ' LEU . 4.6 t80 -123.24 126.28 46.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.411 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.89 167.26 20.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 122.413 0.285 . . . . 0.0 110.323 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER 66.86 154.81 0.09 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.029 0.919 . . . . 0.0 111.522 178.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -66.35 -27.45 67.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.515 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 17.9 mmtt -94.5 -124.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.685 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -114.85 77.06 0.26 Allowed Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.939 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.457 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 1.5 t80 -109.93 156.48 20.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 118.942 1.371 . . . . 0.0 109.606 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 7' ' ' TRP . . . 143.99 -148.82 20.75 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.595 -1.288 . . . . 0.0 115.712 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 25' ' ' VAL . 12.1 m-85 -133.21 143.38 49.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.011 -1.094 . . . . 0.0 109.418 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -129.79 155.91 41.73 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.894 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 23' ' ' GLY . 90.4 m -121.89 116.44 24.4 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.665 -0.647 . . . . 0.0 110.579 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.76 145.56 55.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.763 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -6.91 -92.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.784 1.233 . . . . 0.0 114.043 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.12 31.16 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.625 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.93 -108.93 3.13 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.78 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.813 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.85 -145.64 5.23 Favored Glycine 0 C--O 1.22 -0.724 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.4 p30 -117.69 161.86 18.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.433 0.635 . . . . 0.0 111.555 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -126.32 178.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 122.51 1.148 . . . . 0.0 111.54 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.56 ' N ' HG13 ' A' ' 25' ' ' VAL . 84.4 t80 -130.83 128.19 40.15 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 112.274 -2.239 . . . . 0.0 106.074 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.557 HG11 ' CG1' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -121.33 143.77 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.393 -176.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.456 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 8.7 t-80 -92.02 -21.85 20.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.685 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 103.67 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.132 0.878 . . . . 0.0 111.082 -176.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.89 17.91 11.79 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.901 1.375 . . . . 0.0 108.113 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.617 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.447 -0.592 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.793 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.855 HD12 ' CG1' ' A' ' 5' ' ' VAL . 3.4 mm? . . . . . 0 N--CA 1.413 -2.285 0 CA-C-O 122.39 1.09 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.14 -9.46 59.71 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.787 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 2.5 mp0 66.82 5.79 4.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.478 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.69 45.87 0.83 Allowed Glycine 0 CA--C 1.506 -0.508 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.011 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.4 mt-30 -141.49 -163.29 1.54 Allowed 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.492 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.836 HG12 ' CG2' ' A' ' 65' ' ' VAL . 76.7 t -118.52 132.59 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.23 176.11 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -175.372 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 35.4 tp10 -120.29 91.56 3.57 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.656 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -138.69 167.57 21.69 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -175.162 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -120.94 149.38 42.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.428 -1.715 . . . . 0.0 107.083 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.656 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -142.99 125.37 12.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.394 -178.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.729 179.9 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.65 ' O ' HG22 ' A' ' 25' ' ' VAL . 7.0 Cg_exo . . . . . 0 N--CA 1.463 -0.311 0 CA-C-O 120.635 0.181 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.545 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -128.65 152.22 48.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.794 0.806 . . . . 0.0 111.084 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.45 136.71 53.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.179 177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.43 -30.94 6.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.521 0.677 . . . . 0.0 111.209 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 3.6 m-70 -129.49 116.23 18.65 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.617 HG23 ' HB1' ' A' ' 31' ' ' ALA . 38.4 t -131.93 119.54 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.791 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -127.49 -177.72 4.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.11 141.99 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.986 0.812 . . . . 0.0 113.163 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.836 ' CG2' HG12 ' A' ' 45' ' ' VAL . 2.2 m -142.69 177.67 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.214 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.31 -1.143 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.957 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 89.7 mtm-85 -159.48 141.65 13.52 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 122.047 0.927 . . . . 0.0 113.21 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.778 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.16 -145.52 4.76 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.37 -1.287 . . . . 0.0 114.227 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -143.91 159.52 42.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 42' ' ' GLU . 13.8 t -118.97 133.22 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.891 0 CA-C-N 119.514 1.052 . . . . 0.0 109.244 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -122.77 -26.25 4.51 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 126.001 2.063 . . . . 0.0 111.936 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 79.1 m95 -157.01 137.01 12.6 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.893 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 12.0 t80 -121.38 121.85 38.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.453 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.05 171.63 13.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 p 65.84 146.51 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.402 0.62 . . . . 0.0 109.886 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -64.92 -16.01 62.76 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 18.9 mttt -105.76 -126.59 0.24 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.676 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -111.0 74.5 0.21 Allowed Glycine 0 C--N 1.345 1.072 0 C-N-CA 119.22 -1.467 . . . . 0.0 116.356 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 35.5 t80 -113.87 159.73 19.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 118.434 1.117 . . . . 0.0 108.078 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.28 -152.66 24.49 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.764 -1.208 . . . . 0.0 115.199 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 13.8 m-85 -133.18 144.19 49.69 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.654 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -132.2 157.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.354 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 23' ' ' GLY . 77.5 m -121.8 119.01 30.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.694 0.679 . . . . 0.0 110.314 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -65.69 142.86 57.88 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.668 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 19' ' ' LYS . 44.1 t0 -4.63 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.649 1.18 . . . . 0.0 113.86 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -115.73 31.76 6.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.79 -106.88 3.08 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.72 -142.42 4.62 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 121.569 -0.348 . . . . 0.0 112.382 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 12.1 p-10 -118.86 161.92 19.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.667 0.746 . . . . 0.0 111.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG12 ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -129.67 -177.11 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.741 -179.028 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.601 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.9 m-85 -129.3 155.99 44.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.897 -1.956 . . . . 0.0 106.423 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -148.34 138.97 17.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.462 ' CE1' ' CZ2' ' A' ' 29' ' ' TRP . 9.0 t-160 -92.19 -47.71 7.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.676 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 1.1 p90 142.78 -2.1 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.409 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 t -114.65 21.45 14.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 124.519 1.137 . . . . 0.0 109.2 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.893 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.422 -1.836 0 CA-C-O 121.343 0.592 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -5.18 55.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.712 ' HA ' HG12 ' A' ' 5' ' ' VAL . 5.7 mt-10 82.17 -7.52 1.33 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.55 76.24 0.3 Allowed Glycine 0 N--CA 1.459 0.228 0 CA-C-O 119.482 -0.621 . . . . 0.0 112.926 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.625 ' OE1' HG22 ' A' ' 64' ' ' VAL . 27.5 pt20 -164.83 -162.07 0.61 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.327 1.063 . . . . 0.0 111.244 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.83 HG12 ' CG2' ' A' ' 65' ' ' VAL . 86.9 t -125.15 132.04 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.92 176.03 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.975 -175.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 17.5 tp10 -116.41 97.17 5.88 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -139.84 171.39 14.28 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -174.013 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.3 tm-20 -110.02 151.56 27.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.373 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.64 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -146.88 112.62 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.873 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.07 -179.722 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.598 ' O ' HG22 ' A' ' 25' ' ' VAL . 83.5 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 CA-C-O 120.69 0.204 . . . . 0.0 112.526 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 5.0 tt0 -130.23 156.83 43.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.471 0.653 . . . . 0.0 111.025 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.719 ' HB1' ' CG2' ' A' ' 62' ' ' VAL . . . -67.89 129.29 39.46 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.324 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.78 -33.23 6.81 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.675 0.75 . . . . 0.0 110.127 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 4.0 m-70 -130.06 117.66 20.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.719 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 60.2 t -129.78 102.65 7.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.797 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.5 mttt -109.72 -172.54 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.625 HG22 ' OE1' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -121.05 146.65 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.83 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -152.52 175.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.686 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.84 179.677 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.441 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 3.9 ttp . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -163.79 140.12 6.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.758 0.789 . . . . 0.0 112.108 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.836 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.67 -134.47 3.13 Favored Glycine 0 C--O 1.22 -0.757 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.488 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 30.2 mttp -137.68 163.86 30.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 42' ' ' GLU . 12.8 t -123.81 134.77 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.93 -27.46 4.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 126.159 2.162 . . . . 0.0 112.377 -178.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 78.3 m95 -156.82 138.27 13.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.874 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 27.4 t80 -122.15 86.84 2.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' TYR . 3.3 t70 -89.5 166.38 13.72 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.854 -0.529 . . . . 0.0 110.049 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 1.2 t 64.1 145.03 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.685 0.755 . . . . 0.0 111.051 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -66.15 -16.37 63.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 27.3 mmtt -100.45 -140.31 0.33 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.683 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -98.93 70.26 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.112 -1.518 . . . . 0.0 115.274 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 t80 -113.86 148.29 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.06 -155.31 26.26 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 119.634 -1.27 . . . . 0.0 115.124 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 11.9 m-85 -132.83 139.48 47.5 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.322 -0.939 . . . . 0.0 109.437 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.619 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.25 148.78 31.03 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.417 -178.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 23' ' ' GLY . 72.8 m -121.02 115.62 23.5 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.347 -0.846 . . . . 0.0 109.893 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -63.71 157.22 24.75 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.776 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -23.95 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 45.48 1.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.429 0.633 . . . . 0.0 111.092 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 -115.31 2.76 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.16 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.817 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.29 -146.94 5.52 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.5 p30 -116.05 158.57 22.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.513 0.673 . . . . 0.0 111.042 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -124.32 178.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 122.625 1.202 . . . . 0.0 111.815 -177.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.56 ' N ' HG13 ' A' ' 25' ' ' VAL . 9.1 m-85 -131.65 131.46 43.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.077 -2.328 . . . . 0.0 105.092 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' GLY . 1.6 m -121.15 148.72 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 0.8 OUTLIER -95.8 -46.16 6.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -173.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.683 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 139.69 -4.01 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 124.119 0.968 . . . . 0.0 111.048 -177.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.33 21.07 14.99 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 124.67 1.231 . . . . 0.0 109.292 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.647 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.874 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 122.202 1.001 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -81.46 -5.89 58.39 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.231 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.758 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.5 OUTLIER 77.87 -5.05 2.16 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.6 52.85 0.59 Allowed Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.897 -0.391 . . . . 0.0 112.669 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 4.9 mt-30 -143.52 -164.47 1.87 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.426 0.613 . . . . 0.0 110.937 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' A' ' 65' ' ' VAL . 79.5 t -119.62 131.12 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.17 171.97 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 3.4 tt0 -115.97 95.43 5.1 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.62 ' CE1' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -136.43 173.27 11.89 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -174.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -126.24 137.66 53.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.06 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -130.73 126.03 59.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.097 0.475 . . . . 0.0 112.035 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 C--O 1.233 0.235 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.028 -179.742 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 N--CA 1.461 -0.387 0 N-CA-C 113.0 0.346 . . . . 0.0 113.0 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.617 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -130.95 158.72 39.49 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -67.81 126.86 30.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.324 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.57 -27.67 10.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.402 0.62 . . . . 0.0 111.536 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.508 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 1.5 m-70 -128.65 115.91 18.77 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.647 HG23 ' HB1' ' A' ' 31' ' ' ALA . 51.3 t -126.97 109.54 20.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.815 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.7 mttp -113.96 -178.64 3.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.644 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.96 146.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.13 0.877 . . . . 0.0 112.941 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.5 m -152.12 175.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.311 -1.095 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.944 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 4.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -162.31 137.65 7.18 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.787 0.803 . . . . 0.0 111.732 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.85 -117.46 1.44 Allowed Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.183 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 45' ' ' VAL . 14.7 mtmt -158.6 169.74 23.73 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.013 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -120.6 138.94 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.771 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HD3' ' CD1' ' A' ' 7' ' ' TRP . 13.5 ptpt -122.98 -30.29 3.8 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 126.443 2.34 . . . . 0.0 112.16 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.435 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 63.0 m95 -152.02 128.38 10.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.642 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 35.8 t80 -115.48 120.63 40.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.805 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.87 174.26 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.41 ' CB ' ' CB ' ' A' ' 14' ' ' TYR . 7.6 t 64.6 147.18 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.54 0.686 . . . . 0.0 110.337 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -15.96 62.59 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.777 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' A' ' 29' ' ' TRP . 18.7 mttt -105.64 -140.66 0.37 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -100.46 80.15 0.46 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 15.9 t80 -117.49 154.25 31.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.7 -154.4 25.81 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 119.748 -1.215 . . . . 0.0 115.052 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -133.18 138.03 46.43 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.272 -0.964 . . . . 0.0 109.897 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.769 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -122.12 161.41 22.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.496 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 23' ' ' GLY . 91.5 m -125.39 118.95 27.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.124 0.874 . . . . 0.0 110.778 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' ASP . 5.9 ptpt -67.2 144.8 55.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.509 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' LYS . 15.4 t70 -5.76 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.819 1.248 . . . . 0.0 114.1 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.33 31.04 6.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.79 -109.54 3.18 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.769 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.787 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.36 -146.57 5.45 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 9.9 p-10 -119.21 150.3 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.828 0.823 . . . . 0.0 112.223 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.769 HG12 ' HB ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -114.9 -173.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.541 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.594 ' N ' HG13 ' A' ' 25' ' ' VAL . 6.0 m-85 -127.7 162.1 27.36 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.424 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -156.43 143.51 10.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -105.51 -47.65 3.87 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -174.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.561 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 46.3 p-90 165.68 -25.96 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.09 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 1.1 p -117.79 30.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 124.669 1.231 . . . . 0.0 107.916 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.694 0 CA-C-N 113.659 -1.609 . . . . 0.0 108.494 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.642 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.427 -1.585 0 CA-C-O 121.806 0.813 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.43 -12.79 59.52 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.501 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 7' ' ' TRP . 0.3 OUTLIER 69.69 2.09 3.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.81 54.76 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.3 mt-30 -145.62 -164.47 1.96 Allowed 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 117.256 0.528 . . . . 0.0 110.405 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.87 HG12 ' CG2' ' A' ' 65' ' ' VAL . 79.2 t -118.52 128.12 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -113.55 171.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.053 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.07 93.39 4.16 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -135.92 170.85 15.34 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -123.41 136.58 54.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.236 0.349 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.852 -179.878 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' O ' HG22 ' A' ' 25' ' ' VAL . 85.0 Cg_endo . . . . . 0 N--CA 1.461 -0.413 0 N-CA-C 111.362 -0.284 . . . . 0.0 111.362 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.555 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -131.62 151.03 51.93 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.942 0.877 . . . . 0.0 112.327 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.811 ' O ' ' HB1' ' A' ' 31' ' ' ALA . . . -68.93 151.13 46.94 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.541 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.0 -37.17 2.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.664 0.745 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.6 m-70 -129.13 115.35 17.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.715 HG13 HG11 ' A' ' 46' ' ' VAL . 69.6 t -128.83 135.66 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.0 112.039 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.802 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -130.5 -175.95 3.81 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.61 135.94 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.648 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.87 ' CG2' HG12 ' A' ' 45' ' ' VAL . 2.5 m -142.76 177.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.836 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.975 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.875 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 47' ' ' GLU . 47.4 mtt180 -158.49 142.21 15.32 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.801 0.81 . . . . 0.0 113.133 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.762 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -140.72 -146.97 4.87 Favored Glycine 0 CA--C 1.497 -1.082 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.522 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 1.4 mttt -136.6 163.91 29.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 42' ' ' GLU . 17.3 t -119.28 133.49 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.755 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 4.0 pttt -121.86 -29.47 4.29 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 126.007 2.067 . . . . 0.0 112.997 -175.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 67.3 m95 -153.41 141.04 19.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 20.4 t80 -120.83 137.88 54.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.129 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 7.8 m-20 -134.22 120.9 20.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.421 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 1.8 m 60.11 154.61 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 122.05 0.929 . . . . 0.0 111.963 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -64.42 -29.76 70.82 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 14' ' ' TYR . 43.8 mmtt -75.13 94.72 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.637 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -17.16 74.45 0.0 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.2 t80 -115.49 150.71 36.08 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.54 -160.07 28.57 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 119.437 -1.363 . . . . 0.0 115.075 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.14 129.55 38.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.009 -1.095 . . . . 0.0 110.11 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.848 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -112.9 171.08 3.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.571 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 23' ' ' GLY . 97.1 m -121.24 125.22 46.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 110.135 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -65.52 118.6 9.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' ' HA2' ' A' ' 3' ' ' GLY . 27.6 t70 36.2 -88.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.796 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.3 pp20? -118.96 -36.47 3.41 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.74 -13.13 5.21 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 18' ' ' THR . . . -87.63 -174.95 48.44 Favored Glycine 0 C--N 1.323 -0.165 0 C-N-CA 119.577 -1.297 . . . . 0.0 112.763 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.7 m-20 -154.47 135.65 13.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.534 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.92 HG21 HG22 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -119.67 -177.75 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 122.407 1.099 . . . . 0.0 111.838 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.611 ' N ' HG13 ' A' ' 25' ' ' VAL . 17.1 m-85 -130.95 164.61 24.94 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.61 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' GLY . 1.6 m -148.69 147.27 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.487 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -96.26 -57.09 2.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.637 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 170.25 -30.31 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.967 -0.458 . . . . 0.0 111.579 -178.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -118.23 29.78 7.59 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 124.936 1.397 . . . . 0.0 107.959 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . . . . . . 0 N--CA 1.439 -0.995 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.302 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.628 ' HB3' HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.429 -1.485 0 CA-C-O 121.787 0.803 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -93.01 -10.09 37.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.173 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 75.16 -2.1 2.91 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.89 56.82 0.55 Allowed Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.126 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.1 mt-30 -143.94 -167.13 2.52 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 117.879 0.84 . . . . 0.0 111.105 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.851 HG12 ' CG2' ' A' ' 65' ' ' VAL . 85.0 t -122.18 129.63 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.21 175.65 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.082 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.28 96.83 5.6 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -143.98 173.39 11.76 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 117.63 2.455 . . . . 0.0 117.63 -175.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.4 148.79 41.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.92 HG22 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -140.54 120.45 12.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.834 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 . . . . . 0 C--O 1.235 0.334 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.782 179.844 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo . . . . . 0 C--O 1.23 0.119 0 N-CA-C 111.562 -0.207 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.648 ' HA ' HG22 ' A' ' 25' ' ' VAL . 1.8 tt0 -132.73 151.63 51.93 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.859 0.838 . . . . 0.0 112.75 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.69 ' HB2' HG11 ' A' ' 25' ' ' VAL . . . -70.09 145.7 51.44 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 113.847 -1.524 . . . . 0.0 107.271 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.38 -34.16 3.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.515 0.674 . . . . 0.0 111.108 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 5.8 m-70 -129.04 113.14 14.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.752 HG13 HG11 ' A' ' 46' ' ' VAL . 77.0 t -128.93 139.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.782 0.801 . . . . 0.0 112.454 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.809 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 mttm -135.9 -172.75 3.19 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.76 144.36 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.328 0.967 . . . . 0.0 113.193 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.851 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -151.67 174.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.466 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--N 1.31 -1.15 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.943 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 13.6 mmt . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 47' ' ' GLU . 48.9 mtt85 -158.95 138.53 11.69 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.977 0.894 . . . . 0.0 113.123 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.32 -134.17 3.12 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 114.167 -1.378 . . . . 0.0 113.151 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 17' ' ' ILE . 2.0 ttmm -159.33 167.53 28.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.595 ' CG1' HD12 ' A' ' 40' ' ' LEU . 1.6 t -117.51 130.81 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.194 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 16' ' ' PHE . 8.0 ptmt -123.48 -38.25 2.56 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 126.116 2.135 . . . . 0.0 112.726 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.427 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 78.3 m95 -141.44 135.45 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.566 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CE1' HD23 ' A' ' 40' ' ' LEU . 14.8 t80 -120.43 133.8 55.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.306 0.574 . . . . 0.0 112.353 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 4.6 m-20 -133.76 136.37 44.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.233 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' CZ ' ' A' ' 8' ' ' PHE . 10.0 t 60.97 146.47 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.953 0.882 . . . . 0.0 111.905 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mppp? -66.66 -12.71 59.42 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.787 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 29' ' ' TRP . 2.8 mmtp -100.58 105.02 16.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.641 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -10.46 70.27 0.0 OUTLIER Glycine 0 CA--C 1.531 1.064 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -118.07 141.96 47.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 -147.87 17.51 Favored Glycine 0 CA--C 1.501 -0.828 0 C-N-CA 118.794 -1.669 . . . . 0.0 115.768 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 26' ' ' PHE . 3.9 m-85 -132.98 145.54 50.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.157 -1.021 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.674 HD11 HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -130.88 159.11 43.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.103 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.804 HG23 ' O ' ' A' ' 23' ' ' GLY . 97.4 m -123.91 118.6 27.44 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.628 1.104 . . . . 0.0 111.643 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.14 130.08 41.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.764 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.5 t0 9.04 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.335 1.454 . . . . 0.0 113.997 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.38 24.89 11.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.47 0.176 . . . . 0.0 111.197 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.88 -107.41 2.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.487 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.804 ' O ' HG23 ' A' ' 18' ' ' THR . . . -133.63 -143.89 5.04 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -118.37 163.29 16.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.621 0.724 . . . . 0.0 111.853 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -127.24 -175.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.785 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.585 ' N ' HG13 ' A' ' 25' ' ' VAL . 55.6 m-85 -128.55 157.71 40.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.928 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.674 HG11 HD11 ' A' ' 17' ' ' ILE . 1.8 m -149.19 148.95 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.963 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -89.88 -61.3 1.72 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -174.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 17.8 p-90 169.32 -27.86 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 121.969 -0.457 . . . . 0.0 111.687 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.457 ' CB ' ' CE3' ' A' ' 29' ' ' TRP . 10.2 t -118.9 32.47 6.12 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . . . . . . 0 N--CA 1.438 -1.035 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.331 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.818 HD23 ' CE1' ' A' ' 8' ' ' PHE . 2.1 mm? . . . . . 0 N--CA 1.414 -2.257 0 CA-C-O 122.328 1.061 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 1.4 mmtt -78.12 -6.49 54.89 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.48 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.467 ' HA ' HG12 ' A' ' 5' ' ' VAL . 15.9 pm0 53.93 15.28 0.82 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.348 0.659 . . . . 0.0 112.585 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.78 49.8 0.67 Allowed Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 7.0 mt-30 -144.4 -168.87 3.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 117.85 0.825 . . . . 0.0 111.663 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.831 HG12 ' CG2' ' A' ' 65' ' ' VAL . 74.8 t -120.67 130.15 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.896 HG11 HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -113.93 176.49 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.583 -174.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 1.8 tt0 -117.7 96.62 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -145.26 167.87 21.79 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -175.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -121.24 146.13 47.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.089 -1.869 . . . . 0.0 106.372 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.661 HG21 HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -140.24 136.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.719 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.669 ' O ' HG22 ' A' ' 25' ' ' VAL . 94.4 Cg_endo . . . . . 0 N--CA 1.461 -0.433 0 N-CA-C 112.791 0.266 . . . . 0.0 112.791 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.488 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 2.1 tt0 -130.5 152.49 49.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 111.083 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.67 ' HB1' ' CG2' ' A' ' 62' ' ' VAL . . . -69.54 138.46 53.29 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.013 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.95 -38.3 2.97 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.826 0.822 . . . . 0.0 109.792 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 17.7 m-70 -129.77 110.79 12.03 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.896 HG13 HG11 ' A' ' 46' ' ' VAL . 87.5 t -127.95 139.06 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.444 0.64 . . . . 0.0 111.666 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.3 mttp -134.46 -171.15 2.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.81 144.2 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.303 0.956 . . . . 0.0 113.175 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.831 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.5 m -151.36 175.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.491 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 . . . . . 0 C--N 1.309 -1.164 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.869 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 10.1 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -164.29 145.63 8.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.995 0.903 . . . . 0.0 112.096 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.855 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -141.66 -135.89 3.19 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 114.199 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 5.1 mttt -135.99 161.73 34.85 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 42' ' ' GLU . 14.1 t -121.88 135.7 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.785 0 CA-C-N 119.208 0.913 . . . . 0.0 108.71 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.61 -28.5 4.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.422 2.326 . . . . 0.0 112.764 -177.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.43 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 70.6 m95 -156.85 134.65 10.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.892 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 25.9 t80 -121.08 126.21 49.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.198 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -132.27 174.19 10.48 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 62.56 146.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -65.94 -15.98 63.46 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.757 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 4.4 mptt -105.39 -137.27 0.36 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.692 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -100.62 72.91 0.42 Allowed Glycine 0 CA--C 1.525 0.664 0 C-N-CA 119.703 -1.237 . . . . 0.0 115.657 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 27' ' ' VAL . 13.3 t80 -113.07 153.54 28.0 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.34 -157.65 27.41 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 119.699 -1.238 . . . . 0.0 115.527 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -133.17 136.81 45.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.364 -0.918 . . . . 0.0 110.075 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.822 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -124.22 168.23 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.832 HG23 ' O ' ' A' ' 23' ' ' GLY . 63.7 m -125.08 123.48 39.84 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -69.19 141.99 54.39 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.577 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 19' ' ' LYS . 30.2 t0 -2.39 -91.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -116.16 29.93 7.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.675 0.274 . . . . 0.0 110.954 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.01 -111.07 3.36 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.967 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.832 ' O ' HG23 ' A' ' 18' ' ' THR . . . -132.61 -141.37 4.63 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 3.3 p30 -119.59 145.42 46.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.096 0.95 . . . . 0.0 112.933 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.083 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -114.28 -173.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.87 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.613 ' N ' HG13 ' A' ' 25' ' ' VAL . 12.5 m-85 -130.6 164.93 23.87 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.672 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.073 HG21 HD11 ' A' ' 32' ' ' ILE . 1.4 m -148.9 145.69 17.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 29' ' ' TRP . 2.7 t-160 -98.25 -47.48 5.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.681 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 27.0 p-90 146.16 -11.45 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.528 1.131 . . . . 0.0 109.73 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -113.13 25.64 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.057 0.848 . . . . 0.0 109.22 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -121.27 -29.8 4.42 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.073 HD11 HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -114.8 61.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.661 0 CA-C-O 123.365 1.555 . . . . 0.0 108.173 176.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 1.1 mm-40 -124.34 84.01 2.22 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 111.989 -2.368 . . . . 0.0 110.643 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.3 175.63 6.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -122.91 21.05 9.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.746 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.89 -61.94 0.32 Allowed Glycine 0 C--N 1.33 0.25 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -164.29 94.56 0.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.065 0.46 . . . . 0.0 109.998 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.813 ' CG ' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -126.18 130.19 50.48 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.206 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -172.65 -32.53 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.892 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER 60.69 112.35 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.036 0.922 . . . . 0.0 110.702 -177.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HE3' HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -80.95 -4.59 55.52 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.069 178.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.785 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER 76.29 -0.56 3.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.56 42.68 1.01 Allowed Glycine 0 N--CA 1.463 0.493 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.241 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.5 mt-30 -138.86 -162.01 1.26 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 117.382 0.591 . . . . 0.0 111.359 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.924 HG12 ' CG2' ' A' ' 65' ' ' VAL . 69.8 t -119.58 132.1 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -113.96 172.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -116.29 96.77 5.7 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -140.1 177.8 7.72 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.86 158.16 43.22 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.411 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.083 HD12 HG21 ' A' ' 25' ' ' VAL . 5.5 mm -138.66 142.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.131 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -131.03 133.58 45.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.598 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -117.18 130.5 56.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.77 -124.69 2.65 Favored Glycine 0 CA--C 1.508 -0.35 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.477 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -25.24 64.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.471 -0.364 . . . . 0.0 110.931 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -106.13 -127.36 0.25 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.197 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.75 166.48 12.16 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.452 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 25' ' ' VAL . 11.0 Cg_exo -70.74 127.14 13.43 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.527 2.152 . . . . 0.0 112.184 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 5.7 tt0 -129.76 153.64 48.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.329 0.585 . . . . 0.0 111.075 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.894 ' HA ' HD13 ' A' ' 50' ' ' ILE . . . -68.03 134.21 50.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.813 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.07 -30.22 7.06 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.482 0.658 . . . . 0.0 111.071 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 11.0 m-70 -129.39 117.75 21.09 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.557 HG23 ' HB1' ' A' ' 31' ' ' ALA . 37.4 t -132.36 115.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.834 ' O ' HG22 ' A' ' 46' ' ' VAL . 9.7 mtpt -118.97 -175.51 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG21 ' HE3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -120.83 146.6 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.171 0.896 . . . . 0.0 113.068 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.924 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -152.1 175.04 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.655 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--N 1.309 -1.184 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.917 179.804 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.9 mmt . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HD2' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -161.4 138.91 8.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.901 0.858 . . . . 0.0 111.092 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.653 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -140.06 -120.38 1.73 Allowed Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.561 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.6 ttmt -158.38 167.41 29.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.709 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.855 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -120.85 138.13 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.024 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -123.93 -32.58 3.25 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 126.684 2.49 . . . . 0.0 112.113 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 70.1 m95 -152.07 139.4 19.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.78 ' CE1' HD23 ' A' ' 40' ' ' LEU . 4.6 t80 -123.24 126.28 46.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.411 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.89 167.26 20.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 122.413 0.285 . . . . 0.0 110.323 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER 66.86 154.81 0.09 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.029 0.919 . . . . 0.0 111.522 178.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -66.35 -27.45 67.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.515 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 17.9 mmtt -94.5 -124.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.685 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -114.85 77.06 0.26 Allowed Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.939 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.457 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 1.5 t80 -109.93 156.48 20.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 118.942 1.371 . . . . 0.0 109.606 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 7' ' ' TRP . . . 143.99 -148.82 20.75 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.595 -1.288 . . . . 0.0 115.712 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 25' ' ' VAL . 12.1 m-85 -133.21 143.38 49.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.011 -1.094 . . . . 0.0 109.418 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -129.79 155.91 41.73 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.894 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 23' ' ' GLY . 90.4 m -121.89 116.44 24.4 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.665 -0.647 . . . . 0.0 110.579 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.76 145.56 55.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.763 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -6.91 -92.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.784 1.233 . . . . 0.0 114.043 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.12 31.16 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.625 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.93 -108.93 3.13 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.78 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.813 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.85 -145.64 5.23 Favored Glycine 0 C--O 1.22 -0.724 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.4 p30 -117.69 161.86 18.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.433 0.635 . . . . 0.0 111.555 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -126.32 178.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 122.51 1.148 . . . . 0.0 111.54 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.56 ' N ' HG13 ' A' ' 25' ' ' VAL . 84.4 t80 -130.83 128.19 40.15 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 112.274 -2.239 . . . . 0.0 106.074 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -121.33 143.77 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.393 -176.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.456 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 8.7 t-80 -92.02 -21.85 20.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.685 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 103.67 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.132 0.878 . . . . 0.0 111.082 -176.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.89 17.91 11.79 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.901 1.375 . . . . 0.0 108.113 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.617 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -123.66 -29.63 3.71 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.793 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.953 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -115.53 59.21 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 123.497 1.618 . . . . 0.0 108.253 176.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -125.16 87.9 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 112.038 -2.346 . . . . 0.0 110.216 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.411 ' CB ' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -120.29 167.85 11.87 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.582 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -121.98 19.0 10.9 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.45 -60.24 0.32 Allowed Glycine 0 CA--C 1.508 -0.349 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -165.05 80.68 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.007 -0.597 . . . . 0.0 109.708 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HG2' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -115.28 123.37 48.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.924 ' C ' HD22 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -162.91 164.06 26.04 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 122.581 1.182 . . . . 0.0 111.652 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.953 HD21 ' CG2' ' A' ' 32' ' ' ILE . 3.4 mm? -132.11 106.39 7.96 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 112.383 -2.19 . . . . 0.0 110.998 -175.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.14 -9.46 59.71 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.787 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 2.5 mp0 66.82 5.79 4.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.478 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.69 45.87 0.83 Allowed Glycine 0 CA--C 1.506 -0.508 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.011 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.4 mt-30 -141.49 -163.29 1.54 Allowed 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.492 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.836 HG12 ' CG2' ' A' ' 65' ' ' VAL . 76.7 t -118.52 132.59 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.23 176.11 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -175.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 35.4 tp10 -120.29 91.56 3.57 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.656 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -138.69 167.57 21.69 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -175.162 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -120.94 149.38 42.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.428 -1.715 . . . . 0.0 107.083 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.656 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -142.99 125.37 12.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.394 -178.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -130.54 167.1 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.729 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -112.87 129.34 56.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.8 -132.49 3.84 Favored Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -59.19 -28.22 66.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.958 0.409 . . . . 0.0 110.716 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -108.51 -124.91 0.25 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.045 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.08 -167.28 16.07 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.087 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.65 ' O ' HG22 ' A' ' 25' ' ' VAL . 7.0 Cg_exo -72.08 113.67 3.75 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.386 2.058 . . . . 0.0 112.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.545 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -128.65 152.22 48.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.794 0.806 . . . . 0.0 111.084 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.45 136.71 53.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.179 177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.43 -30.94 6.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.521 0.677 . . . . 0.0 111.209 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 3.6 m-70 -129.49 116.23 18.65 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.796 ' CG1' HG23 ' A' ' 32' ' ' ILE . 38.4 t -131.93 119.54 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.791 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -127.49 -177.72 4.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.11 141.99 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.986 0.812 . . . . 0.0 113.163 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.836 ' CG2' HG12 ' A' ' 45' ' ' VAL . 2.2 m -142.69 177.67 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.214 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.31 -1.143 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.957 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 89.7 mtm-85 -159.48 141.65 13.52 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 122.047 0.927 . . . . 0.0 113.21 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.778 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.16 -145.52 4.76 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.37 -1.287 . . . . 0.0 114.227 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -143.91 159.52 42.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 42' ' ' GLU . 13.8 t -118.97 133.22 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.891 0 CA-C-N 119.514 1.052 . . . . 0.0 109.244 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -122.77 -26.25 4.51 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 126.001 2.063 . . . . 0.0 111.936 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 79.1 m95 -157.01 137.01 12.6 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.893 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 12.0 t80 -121.38 121.85 38.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.453 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.05 171.63 13.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 p 65.84 146.51 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.402 0.62 . . . . 0.0 109.886 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -64.92 -16.01 62.76 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 18.9 mttt -105.76 -126.59 0.24 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.726 ' HA3' ' HB ' ' A' ' 32' ' ' ILE . . . -111.0 74.5 0.21 Allowed Glycine 0 C--N 1.345 1.072 0 C-N-CA 119.22 -1.467 . . . . 0.0 116.356 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 35.5 t80 -113.87 159.73 19.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 118.434 1.117 . . . . 0.0 108.078 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.28 -152.66 24.49 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.764 -1.208 . . . . 0.0 115.199 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 13.8 m-85 -133.18 144.19 49.69 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.654 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -132.2 157.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.354 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 23' ' ' GLY . 77.5 m -121.8 119.01 30.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.694 0.679 . . . . 0.0 110.314 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -65.69 142.86 57.88 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.668 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 19' ' ' LYS . 44.1 t0 -4.63 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.649 1.18 . . . . 0.0 113.86 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -115.73 31.76 6.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.79 -106.88 3.08 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.72 -142.42 4.62 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 121.569 -0.348 . . . . 0.0 112.382 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 12.1 p-10 -118.86 161.92 19.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.667 0.746 . . . . 0.0 111.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG12 ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -129.67 -177.11 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.741 -179.028 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.601 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.9 m-85 -129.3 155.99 44.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.897 -1.956 . . . . 0.0 106.423 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -148.34 138.97 17.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.462 ' CE1' ' CZ2' ' A' ' 29' ' ' TRP . 9.0 t-160 -92.19 -47.71 7.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.676 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 1.1 p90 142.78 -2.1 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.409 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 t -114.65 21.45 14.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 124.519 1.137 . . . . 0.0 109.2 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -121.45 -25.0 5.26 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -113.71 32.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-O 122.576 1.179 . . . . 0.0 109.776 177.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -119.61 93.5 4.09 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.163 -1.381 . . . . 0.0 112.666 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.484 ' HB2' ' CE ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -121.85 -170.51 2.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.245 178.238 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -120.18 28.52 8.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.123 0.487 . . . . 0.0 110.991 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.38 -100.41 2.19 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.39 78.12 0.36 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.223 0.535 . . . . 0.0 110.88 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' CE ' ' HB2' ' A' ' 34' ' ' MET . 0.0 OUTLIER -120.76 155.05 34.79 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -170.36 168.86 7.83 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.144 -176.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.893 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -120.93 114.18 21.18 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.155 -179.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -5.18 55.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.712 ' HA ' HG12 ' A' ' 5' ' ' VAL . 5.7 mt-10 82.17 -7.52 1.33 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.55 76.24 0.3 Allowed Glycine 0 N--CA 1.459 0.228 0 CA-C-O 119.482 -0.621 . . . . 0.0 112.926 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.625 ' OE1' HG22 ' A' ' 64' ' ' VAL . 27.5 pt20 -164.83 -162.07 0.61 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.327 1.063 . . . . 0.0 111.244 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.83 HG12 ' CG2' ' A' ' 65' ' ' VAL . 86.9 t -125.15 132.04 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.92 176.03 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.975 -175.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 17.5 tp10 -116.41 97.17 5.88 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -139.84 171.39 14.28 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -174.013 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.3 tm-20 -110.02 151.56 27.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.373 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.64 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -146.88 112.62 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.873 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.61 136.04 49.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.07 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -109.94 153.16 24.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.105 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.16 -116.06 2.05 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.76 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -28.37 65.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.511 -0.344 . . . . 0.0 110.426 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.25 -114.34 0.31 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.85 -179.09 18.78 Favored Glycine 0 C--N 1.344 1.022 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.713 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.598 ' O ' HG22 ' A' ' 25' ' ' VAL . 83.5 Cg_endo -82.65 141.38 10.97 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.633 2.222 . . . . 0.0 112.526 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 5.0 tt0 -130.23 156.83 43.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.471 0.653 . . . . 0.0 111.025 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.719 ' HB1' ' CG2' ' A' ' 62' ' ' VAL . . . -67.89 129.29 39.46 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.324 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.78 -33.23 6.81 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.675 0.75 . . . . 0.0 110.127 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 4.0 m-70 -130.06 117.66 20.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.719 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 60.2 t -129.78 102.65 7.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.797 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.5 mttt -109.72 -172.54 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.625 HG22 ' OE1' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -121.05 146.65 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.83 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -152.52 175.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.686 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.84 179.677 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 3.9 ttp . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -163.79 140.12 6.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.758 0.789 . . . . 0.0 112.108 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.836 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.67 -134.47 3.13 Favored Glycine 0 C--O 1.22 -0.757 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.488 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 30.2 mttp -137.68 163.86 30.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 42' ' ' GLU . 12.8 t -123.81 134.77 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.93 -27.46 4.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 126.159 2.162 . . . . 0.0 112.377 -178.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 78.3 m95 -156.82 138.27 13.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.874 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 27.4 t80 -122.15 86.84 2.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' TYR . 3.3 t70 -89.5 166.38 13.72 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.854 -0.529 . . . . 0.0 110.049 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 1.2 t 64.1 145.03 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.685 0.755 . . . . 0.0 111.051 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -66.15 -16.37 63.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 27.3 mmtt -100.45 -140.31 0.33 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.683 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -98.93 70.26 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.112 -1.518 . . . . 0.0 115.274 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 t80 -113.86 148.29 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.06 -155.31 26.26 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 119.634 -1.27 . . . . 0.0 115.124 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 11.9 m-85 -132.83 139.48 47.5 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.322 -0.939 . . . . 0.0 109.437 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.619 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.25 148.78 31.03 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.417 -178.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 23' ' ' GLY . 72.8 m -121.02 115.62 23.5 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.347 -0.846 . . . . 0.0 109.893 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -63.71 157.22 24.75 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.776 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -23.95 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 45.48 1.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.429 0.633 . . . . 0.0 111.092 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 -115.31 2.76 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.16 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.817 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.29 -146.94 5.52 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.5 p30 -116.05 158.57 22.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.513 0.673 . . . . 0.0 111.042 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -124.32 178.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 122.625 1.202 . . . . 0.0 111.815 -177.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.56 ' N ' HG13 ' A' ' 25' ' ' VAL . 9.1 m-85 -131.65 131.46 43.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.077 -2.328 . . . . 0.0 105.092 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.886 HG21 HD11 ' A' ' 32' ' ' ILE . 1.6 m -121.15 148.72 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 0.8 OUTLIER -95.8 -46.16 6.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -173.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.683 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 139.69 -4.01 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 124.119 0.968 . . . . 0.0 111.048 -177.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -114.33 21.07 14.99 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 124.67 1.231 . . . . 0.0 109.292 177.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.647 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -121.64 -24.26 5.36 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -114.3 41.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.69 0 CA-C-O 122.841 1.305 . . . . 0.0 109.72 177.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -114.38 90.79 3.43 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.878 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.11 -175.58 3.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.07 23.03 10.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.961 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -117.23 -74.18 0.51 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -164.86 76.46 0.29 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.804 0.335 . . . . 0.0 110.851 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -116.05 111.09 19.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.549 0.69 . . . . 0.0 110.304 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.499 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -147.79 -24.07 0.37 Allowed 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.964 -176.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.874 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER 61.86 118.14 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.202 1.001 . . . . 0.0 110.741 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -81.46 -5.89 58.39 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.231 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.758 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.5 OUTLIER 77.87 -5.05 2.16 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.6 52.85 0.59 Allowed Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.897 -0.391 . . . . 0.0 112.669 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 4.9 mt-30 -143.52 -164.47 1.87 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.426 0.613 . . . . 0.0 110.937 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' A' ' 65' ' ' VAL . 79.5 t -119.62 131.12 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.17 171.97 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 3.4 tt0 -115.97 95.43 5.1 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.62 ' CE1' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -136.43 173.27 11.89 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -174.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -126.24 137.66 53.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.06 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -130.73 126.03 59.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.097 0.475 . . . . 0.0 112.035 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -129.63 140.75 51.08 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.028 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HB3' ' N ' ' A' ' 57' ' ' PRO . 6.6 pt-20 -112.41 163.15 14.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.609 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.02 -111.76 1.5 Allowed Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -81.92 -25.0 35.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.164 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -110.03 -125.18 0.27 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.541 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.26 166.82 13.98 Favored Glycine 0 C--N 1.344 0.996 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.411 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' N ' ' HB3' ' A' ' 52' ' ' GLU . 94.4 Cg_endo -85.15 147.12 10.19 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.446 2.097 . . . . 0.0 113.0 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.617 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -130.95 158.72 39.49 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -67.81 126.86 30.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.324 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.57 -27.67 10.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.402 0.62 . . . . 0.0 111.536 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.508 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 1.5 m-70 -128.65 115.91 18.77 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.647 HG23 ' HB1' ' A' ' 31' ' ' ALA . 51.3 t -126.97 109.54 20.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.815 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.7 mttp -113.96 -178.64 3.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.644 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.96 146.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.13 0.877 . . . . 0.0 112.941 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.5 m -152.12 175.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.311 -1.095 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.944 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 4.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -162.31 137.65 7.18 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.787 0.803 . . . . 0.0 111.732 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.85 -117.46 1.44 Allowed Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.183 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 45' ' ' VAL . 14.7 mtmt -158.6 169.74 23.73 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.013 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -120.6 138.94 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.771 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HD3' ' CD1' ' A' ' 7' ' ' TRP . 13.5 ptpt -122.98 -30.29 3.8 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 126.443 2.34 . . . . 0.0 112.16 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.435 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 63.0 m95 -152.02 128.38 10.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.652 ' HE1' HD12 ' A' ' 32' ' ' ILE . 35.8 t80 -115.48 120.63 40.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.805 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.87 174.26 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.41 ' CB ' ' CB ' ' A' ' 14' ' ' TYR . 7.6 t 64.6 147.18 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.54 0.686 . . . . 0.0 110.337 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -15.96 62.59 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.777 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' A' ' 29' ' ' TRP . 18.7 mttt -105.64 -140.66 0.37 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -100.46 80.15 0.46 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 15.9 t80 -117.49 154.25 31.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.7 -154.4 25.81 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 119.748 -1.215 . . . . 0.0 115.052 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -133.18 138.03 46.43 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.272 -0.964 . . . . 0.0 109.897 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.769 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -122.12 161.41 22.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.496 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 23' ' ' GLY . 91.5 m -125.39 118.95 27.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.124 0.874 . . . . 0.0 110.778 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' ASP . 5.9 ptpt -67.2 144.8 55.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.509 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' LYS . 15.4 t70 -5.76 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.819 1.248 . . . . 0.0 114.1 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.33 31.04 6.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.79 -109.54 3.18 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.769 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.787 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.36 -146.57 5.45 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 9.9 p-10 -119.21 150.3 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.828 0.823 . . . . 0.0 112.223 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.769 HG12 ' HB ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -114.9 -173.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.541 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.594 ' N ' HG13 ' A' ' 25' ' ' VAL . 6.0 m-85 -127.7 162.1 27.36 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.424 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.66 HG21 HD11 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -156.43 143.51 10.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -105.51 -47.65 3.87 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -174.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.561 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 46.3 p-90 165.68 -25.96 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.09 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 1.1 p -117.79 30.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 124.669 1.231 . . . . 0.0 107.916 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . -133.31 28.08 4.08 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 113.659 -1.609 . . . . 0.0 108.494 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.837 HG23 HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -121.68 -95.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 32' ' ' ILE . 2.6 tt0 -122.2 -75.37 0.6 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.17 -158.39 0.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -121.4 21.81 10.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.415 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.53 -83.97 1.05 Allowed Glycine 0 C--N 1.336 0.561 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.72 89.71 3.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.3 0.571 . . . . 0.0 109.677 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -129.09 147.17 50.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -169.41 155.3 6.17 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.837 HD21 HG23 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -119.4 140.95 49.55 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.329 176.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.43 -12.79 59.52 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.501 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 7' ' ' TRP . 0.3 OUTLIER 69.69 2.09 3.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.81 54.76 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.3 mt-30 -145.62 -164.47 1.96 Allowed 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 117.256 0.528 . . . . 0.0 110.405 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.87 HG12 ' CG2' ' A' ' 65' ' ' VAL . 79.2 t -118.52 128.12 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -113.55 171.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.053 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.07 93.39 4.16 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -135.92 170.85 15.34 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -123.41 136.58 54.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -119.89 119.52 33.76 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.852 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -118.51 66.3 0.77 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.99 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.77 -145.14 14.61 Favored Glycine 0 CA--C 1.508 -0.366 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.365 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -24.21 63.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.957 -0.621 . . . . 0.0 111.118 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -90.5 -123.52 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.426 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.91 154.79 16.56 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.081 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' O ' HG22 ' A' ' 25' ' ' VAL . 85.0 Cg_endo -81.63 98.15 0.98 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.488 2.125 . . . . 0.0 111.362 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.555 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -131.62 151.03 51.93 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.942 0.877 . . . . 0.0 112.327 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.811 ' O ' ' HB1' ' A' ' 31' ' ' ALA . . . -68.93 151.13 46.94 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.541 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.0 -37.17 2.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.664 0.745 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.6 m-70 -129.13 115.35 17.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.747 ' HB ' ' HA ' ' A' ' 32' ' ' ILE . 69.6 t -128.83 135.66 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.0 112.039 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.802 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -130.5 -175.95 3.81 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.61 135.94 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.648 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.87 ' CG2' HG12 ' A' ' 45' ' ' VAL . 2.5 m -142.76 177.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.836 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.975 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.875 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 47' ' ' GLU . 47.4 mtt180 -158.49 142.21 15.32 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.801 0.81 . . . . 0.0 113.133 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.762 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -140.72 -146.97 4.87 Favored Glycine 0 CA--C 1.497 -1.082 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.522 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 1.4 mttt -136.6 163.91 29.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 42' ' ' GLU . 17.3 t -119.28 133.49 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.755 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 4.0 pttt -121.86 -29.47 4.29 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 126.007 2.067 . . . . 0.0 112.997 -175.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 67.3 m95 -153.41 141.04 19.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 39' ' ' THR . 20.4 t80 -120.83 137.88 54.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.129 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 7.8 m-20 -134.22 120.9 20.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.421 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 1.8 m 60.11 154.61 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 122.05 0.929 . . . . 0.0 111.963 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -64.42 -29.76 70.82 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 14' ' ' TYR . 43.8 mmtt -75.13 94.72 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.826 ' HA2' HD12 ' A' ' 32' ' ' ILE . . . -17.16 74.45 0.0 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.2 t80 -115.49 150.71 36.08 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.54 -160.07 28.57 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 119.437 -1.363 . . . . 0.0 115.075 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.14 129.55 38.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.009 -1.095 . . . . 0.0 110.11 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.848 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -112.9 171.08 3.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.571 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 23' ' ' GLY . 97.1 m -121.24 125.22 46.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 110.135 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -65.52 118.6 9.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' ' HA2' ' A' ' 3' ' ' GLY . 27.6 t70 36.2 -88.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.796 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.3 pp20? -118.96 -36.47 3.41 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.74 -13.13 5.21 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 18' ' ' THR . . . -87.63 -174.95 48.44 Favored Glycine 0 C--N 1.323 -0.165 0 C-N-CA 119.577 -1.297 . . . . 0.0 112.763 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.7 m-20 -154.47 135.65 13.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.534 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.92 HG21 HG22 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -119.67 -177.75 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 122.407 1.099 . . . . 0.0 111.838 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.611 ' N ' HG13 ' A' ' 25' ' ' VAL . 17.1 m-85 -130.95 164.61 24.94 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.61 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.678 HG21 ' CG1' ' A' ' 32' ' ' ILE . 1.6 m -148.69 147.27 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.487 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -96.26 -57.09 2.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.637 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 170.25 -30.31 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.967 -0.458 . . . . 0.0 111.579 -178.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -118.23 29.78 7.59 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 124.936 1.397 . . . . 0.0 107.959 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . -130.44 31.59 4.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.302 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.968 HG23 HD21 ' A' ' 40' ' ' LEU . 1.2 mt -122.79 -57.81 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.056 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 4.8 tt0 -128.7 -66.73 0.82 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.017 0.913 . . . . 0.0 109.281 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -165.71 -134.62 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.597 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -120.12 28.56 7.99 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.723 -0.611 . . . . 0.0 110.027 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.52 -120.12 3.17 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.604 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.5 120.85 35.07 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.423 0.63 . . . . 0.0 109.908 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.766 ' O ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -145.83 176.65 9.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.694 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.766 HG23 ' O ' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -171.16 161.14 6.6 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.693 0.759 . . . . 0.0 113.035 177.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.968 HD21 HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -117.8 158.13 25.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.383 177.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.447 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -93.01 -10.09 37.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.173 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 75.16 -2.1 2.91 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.89 56.82 0.55 Allowed Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.126 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.1 mt-30 -143.94 -167.13 2.52 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 117.879 0.84 . . . . 0.0 111.105 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.851 HG12 ' CG2' ' A' ' 65' ' ' VAL . 85.0 t -122.18 129.63 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.21 175.65 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.082 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.28 96.83 5.6 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -143.98 173.39 11.76 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 117.63 2.455 . . . . 0.0 117.63 -175.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.4 148.79 41.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.92 HG22 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -140.54 120.45 12.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.834 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -101.3 106.6 17.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.59 61.05 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.11 -132.16 6.25 Favored Glycine 0 CA--C 1.509 -0.296 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.162 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -15.69 58.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.761 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -100.09 -129.18 0.21 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.11 131.74 9.62 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.12 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.7 88.26 0.1 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.066 1.844 . . . . 0.0 111.562 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.648 ' HA ' HG22 ' A' ' 25' ' ' VAL . 1.8 tt0 -132.73 151.63 51.93 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.859 0.838 . . . . 0.0 112.75 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.69 ' HB2' HG11 ' A' ' 25' ' ' VAL . . . -70.09 145.7 51.44 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 113.847 -1.524 . . . . 0.0 107.271 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.38 -34.16 3.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.515 0.674 . . . . 0.0 111.108 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 5.8 m-70 -129.04 113.14 14.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.752 HG13 HG11 ' A' ' 46' ' ' VAL . 77.0 t -128.93 139.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.782 0.801 . . . . 0.0 112.454 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.809 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 mttm -135.9 -172.75 3.19 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.76 144.36 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.328 0.967 . . . . 0.0 113.193 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.851 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -151.67 174.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.466 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--N 1.31 -1.15 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.943 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 13.6 mmt . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 47' ' ' GLU . 48.9 mtt85 -158.95 138.53 11.69 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.977 0.894 . . . . 0.0 113.123 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.32 -134.17 3.12 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 114.167 -1.378 . . . . 0.0 113.151 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 17' ' ' ILE . 2.0 ttmm -159.33 167.53 28.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.595 ' CG1' HD12 ' A' ' 40' ' ' LEU . 1.6 t -117.51 130.81 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.194 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 16' ' ' PHE . 8.0 ptmt -123.48 -38.25 2.56 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 126.116 2.135 . . . . 0.0 112.726 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.427 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 78.3 m95 -141.44 135.45 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.566 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CE1' HD23 ' A' ' 40' ' ' LEU . 14.8 t80 -120.43 133.8 55.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.306 0.574 . . . . 0.0 112.353 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 4.6 m-20 -133.76 136.37 44.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.233 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' CZ ' ' A' ' 8' ' ' PHE . 10.0 t 60.97 146.47 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.953 0.882 . . . . 0.0 111.905 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mppp? -66.66 -12.71 59.42 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.787 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 29' ' ' TRP . 2.8 mmtp -100.58 105.02 16.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.81 ' HA2' HD12 ' A' ' 32' ' ' ILE . . . -10.46 70.27 0.0 OUTLIER Glycine 0 CA--C 1.531 1.064 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -118.07 141.96 47.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 -147.87 17.51 Favored Glycine 0 CA--C 1.501 -0.828 0 C-N-CA 118.794 -1.669 . . . . 0.0 115.768 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 26' ' ' PHE . 3.9 m-85 -132.98 145.54 50.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.157 -1.021 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.674 HD11 HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -130.88 159.11 43.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.103 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.804 HG23 ' O ' ' A' ' 23' ' ' GLY . 97.4 m -123.91 118.6 27.44 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.628 1.104 . . . . 0.0 111.643 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.14 130.08 41.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.764 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.5 t0 9.04 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.335 1.454 . . . . 0.0 113.997 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.38 24.89 11.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.47 0.176 . . . . 0.0 111.197 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.88 -107.41 2.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.487 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.804 ' O ' HG23 ' A' ' 18' ' ' THR . . . -133.63 -143.89 5.04 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -118.37 163.29 16.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.621 0.724 . . . . 0.0 111.853 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -127.24 -175.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.785 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.585 ' N ' HG13 ' A' ' 25' ' ' VAL . 55.6 m-85 -128.55 157.71 40.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.928 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' A' ' 32' ' ' ILE . 1.8 m -149.19 148.95 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.963 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -89.88 -61.3 1.72 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -174.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 17.8 p-90 169.32 -27.86 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 121.969 -0.457 . . . . 0.0 111.687 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.457 ' CB ' ' CE3' ' A' ' 29' ' ' TRP . 10.2 t -118.9 32.47 6.12 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . -135.79 35.75 2.87 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.331 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.993 HG21 HD21 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -123.11 -62.21 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.43 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -131.68 -57.18 1.0 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.229 0.538 . . . . 0.0 110.665 177.304 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -167.56 -147.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.874 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -120.33 27.86 8.36 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.67 -86.57 0.64 Allowed Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.191 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -123.89 107.13 11.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.757 0.313 . . . . 0.0 110.521 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' HB2' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -127.53 136.86 52.31 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.003 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.948 ' C ' HD22 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.58 152.23 49.19 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-O 122.951 1.357 . . . . 0.0 113.464 177.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.993 HD21 HG21 ' A' ' 32' ' ' ILE . 2.1 mm? -128.26 111.47 13.43 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 111.47 -2.604 . . . . 0.0 111.175 -173.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 41' ' ' LYS . 1.4 mmtt -78.12 -6.49 54.89 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.48 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.467 ' HA ' HG12 ' A' ' 5' ' ' VAL . 15.9 pm0 53.93 15.28 0.82 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.348 0.659 . . . . 0.0 112.585 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.78 49.8 0.67 Allowed Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 7.0 mt-30 -144.4 -168.87 3.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 117.85 0.825 . . . . 0.0 111.663 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.831 HG12 ' CG2' ' A' ' 65' ' ' VAL . 74.8 t -120.67 130.15 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.896 HG11 HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -113.93 176.49 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.583 -174.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 1.8 tt0 -117.7 96.62 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -145.26 167.87 21.79 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -175.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -121.24 146.13 47.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.089 -1.869 . . . . 0.0 106.372 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.661 HG21 HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -140.24 136.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -130.33 143.75 50.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.719 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -117.05 144.86 44.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.119 0.485 . . . . 0.0 111.439 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.38 97.83 0.39 Allowed Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.35 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 tptt 69.86 -62.83 0.41 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.277 -0.461 . . . . 0.0 110.822 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -78.68 -112.11 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.19 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.36 173.77 14.93 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.232 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.669 ' O ' HG22 ' A' ' 25' ' ' VAL . 94.4 Cg_endo -88.19 147.53 6.56 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.924 2.416 . . . . 0.0 112.791 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.488 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 2.1 tt0 -130.5 152.49 49.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 111.083 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.67 ' HB1' ' CG2' ' A' ' 62' ' ' VAL . . . -69.54 138.46 53.29 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.013 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.95 -38.3 2.97 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.826 0.822 . . . . 0.0 109.792 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 17.7 m-70 -129.77 110.79 12.03 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.896 HG13 HG11 ' A' ' 46' ' ' VAL . 87.5 t -127.95 139.06 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.444 0.64 . . . . 0.0 111.666 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.3 mttp -134.46 -171.15 2.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.81 144.2 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.303 0.956 . . . . 0.0 113.175 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.831 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.5 m -151.36 175.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.491 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 . . . . . 0 C--N 1.309 -1.164 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.869 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 10.1 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -164.29 145.63 8.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.995 0.903 . . . . 0.0 112.096 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.855 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -141.66 -135.89 3.19 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 114.199 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 5.1 mttt -135.99 161.73 34.85 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 42' ' ' GLU . 14.1 t -121.88 135.7 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.785 0 CA-C-N 119.208 0.913 . . . . 0.0 108.71 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.61 -28.5 4.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.422 2.326 . . . . 0.0 112.764 -177.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.43 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 70.6 m95 -156.85 134.65 10.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.892 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 25.9 t80 -121.08 126.21 49.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.198 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -132.27 174.19 10.48 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 62.56 146.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -65.94 -15.98 63.46 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.757 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 4.4 mptt -105.39 -137.27 0.36 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.692 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -100.62 72.91 0.42 Allowed Glycine 0 CA--C 1.525 0.664 0 C-N-CA 119.703 -1.237 . . . . 0.0 115.657 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 27' ' ' VAL . 13.3 t80 -113.07 153.54 28.0 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.34 -157.65 27.41 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 119.699 -1.238 . . . . 0.0 115.527 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -133.17 136.81 45.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.364 -0.918 . . . . 0.0 110.075 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.822 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -124.22 168.23 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.832 HG23 ' O ' ' A' ' 23' ' ' GLY . 63.7 m -125.08 123.48 39.84 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -69.19 141.99 54.39 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.577 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 19' ' ' LYS . 30.2 t0 -2.39 -91.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -116.16 29.93 7.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.675 0.274 . . . . 0.0 110.954 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.01 -111.07 3.36 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.967 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.832 ' O ' HG23 ' A' ' 18' ' ' THR . . . -132.61 -141.37 4.63 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 3.3 p30 -119.59 145.42 46.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.096 0.95 . . . . 0.0 112.933 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.083 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -114.28 -173.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.87 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.613 ' N ' HG13 ' A' ' 25' ' ' VAL . 12.5 m-85 -130.6 164.93 23.87 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.672 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 13' ' ' GLY . 1.4 m -148.9 145.69 17.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 29' ' ' TRP . 2.7 t-160 -98.25 -47.48 5.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.681 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 27.0 p-90 146.16 -11.45 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.528 1.131 . . . . 0.0 109.73 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -113.13 25.64 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.057 0.848 . . . . 0.0 109.22 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.44 -0.952 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.892 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.973 0 CA-C-O 122.036 0.922 . . . . 0.0 110.702 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HE3' HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -80.95 -4.59 55.52 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.069 178.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.785 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER 76.29 -0.56 3.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.56 42.68 1.01 Allowed Glycine 0 N--CA 1.463 0.493 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.241 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.5 mt-30 -138.86 -162.01 1.26 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 117.382 0.591 . . . . 0.0 111.359 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.924 HG12 ' CG2' ' A' ' 65' ' ' VAL . 69.8 t -119.58 132.1 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -113.96 172.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -116.29 96.77 5.7 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -140.1 177.8 7.72 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.86 158.16 43.22 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.411 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.083 HD12 HG21 ' A' ' 25' ' ' VAL . 5.5 mm -138.66 142.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.131 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.598 179.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 25' ' ' VAL . 11.0 Cg_exo . . . . . 0 N--CA 1.466 -0.132 0 CA-C-O 120.655 0.19 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 5.7 tt0 -129.76 153.64 48.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.329 0.585 . . . . 0.0 111.075 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.894 ' HA ' HD13 ' A' ' 50' ' ' ILE . . . -68.03 134.21 50.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.813 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.07 -30.22 7.06 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.482 0.658 . . . . 0.0 111.071 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 11.0 m-70 -129.39 117.75 21.09 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.557 HG23 ' HB1' ' A' ' 31' ' ' ALA . 37.4 t -132.36 115.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.834 ' O ' HG22 ' A' ' 46' ' ' VAL . 9.7 mtpt -118.97 -175.51 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.531 HG21 ' HE3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -120.83 146.6 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.171 0.896 . . . . 0.0 113.068 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.924 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -152.1 175.04 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.655 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--N 1.309 -1.184 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.917 179.804 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.9 mmt . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HD2' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -161.4 138.91 8.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.901 0.858 . . . . 0.0 111.092 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.653 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -140.06 -120.38 1.73 Allowed Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.561 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.6 ttmt -158.38 167.41 29.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.709 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.855 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -120.85 138.13 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.024 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -123.93 -32.58 3.25 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 126.684 2.49 . . . . 0.0 112.113 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 70.1 m95 -152.07 139.4 19.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.78 ' CE1' HD23 ' A' ' 40' ' ' LEU . 4.6 t80 -123.24 126.28 46.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.411 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.89 167.26 20.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 122.413 0.285 . . . . 0.0 110.323 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER 66.86 154.81 0.09 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.029 0.919 . . . . 0.0 111.522 178.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -66.35 -27.45 67.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.515 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 17.9 mmtt -94.5 -124.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.685 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -114.85 77.06 0.26 Allowed Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.939 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.457 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 1.5 t80 -109.93 156.48 20.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 118.942 1.371 . . . . 0.0 109.606 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 7' ' ' TRP . . . 143.99 -148.82 20.75 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.595 -1.288 . . . . 0.0 115.712 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 25' ' ' VAL . 12.1 m-85 -133.21 143.38 49.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.011 -1.094 . . . . 0.0 109.418 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -129.79 155.91 41.73 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.894 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 23' ' ' GLY . 90.4 m -121.89 116.44 24.4 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.665 -0.647 . . . . 0.0 110.579 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.76 145.56 55.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.763 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -6.91 -92.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.784 1.233 . . . . 0.0 114.043 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.12 31.16 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.625 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.93 -108.93 3.13 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.78 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.813 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.85 -145.64 5.23 Favored Glycine 0 C--O 1.22 -0.724 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.4 p30 -117.69 161.86 18.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.433 0.635 . . . . 0.0 111.555 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -126.32 178.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 122.51 1.148 . . . . 0.0 111.54 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.56 ' N ' HG13 ' A' ' 25' ' ' VAL . 84.4 t80 -130.83 128.19 40.15 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 112.274 -2.239 . . . . 0.0 106.074 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.557 HG11 ' CG1' ' A' ' 17' ' ' ILE . 0.9 OUTLIER -121.33 143.77 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.393 -176.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.456 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 1.6 t60 -92.02 -21.85 20.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.685 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 103.67 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.132 0.878 . . . . 0.0 111.082 -176.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.89 17.91 11.79 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.901 1.375 . . . . 0.0 108.113 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.617 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.447 -0.592 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.793 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.855 HD12 ' CG1' ' A' ' 5' ' ' VAL . 3.4 mm? . . . . . 0 N--CA 1.413 -2.285 0 CA-C-O 122.39 1.09 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.14 -9.46 59.71 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.787 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 2.5 mp0 66.82 5.79 4.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.478 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.69 45.87 0.83 Allowed Glycine 0 CA--C 1.506 -0.508 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.011 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 3.3 mt-30 -141.49 -163.29 1.54 Allowed 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.492 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.836 HG12 ' CG2' ' A' ' 65' ' ' VAL . 76.7 t -118.52 132.59 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.23 176.11 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -175.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 35.4 tp10 -120.29 91.56 3.57 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.656 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -138.69 167.57 21.69 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -175.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -120.94 149.38 42.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.428 -1.715 . . . . 0.0 107.083 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.656 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -142.99 125.37 12.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.394 -178.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.729 179.9 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.65 ' O ' HG22 ' A' ' 25' ' ' VAL . 7.0 Cg_exo . . . . . 0 N--CA 1.463 -0.311 0 CA-C-O 120.635 0.181 . . . . 0.0 112.005 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.545 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -128.65 152.22 48.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.794 0.806 . . . . 0.0 111.084 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.45 136.71 53.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.179 177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.43 -30.94 6.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.521 0.677 . . . . 0.0 111.209 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 3.6 m-70 -129.49 116.23 18.65 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.617 HG23 ' HB1' ' A' ' 31' ' ' ALA . 38.4 t -131.93 119.54 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.791 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -127.49 -177.72 4.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.11 141.99 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.986 0.812 . . . . 0.0 113.163 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.836 ' CG2' HG12 ' A' ' 45' ' ' VAL . 2.2 m -142.69 177.67 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.214 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.31 -1.143 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.957 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 89.7 mtm-85 -159.48 141.65 13.52 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 122.047 0.927 . . . . 0.0 113.21 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.778 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.16 -145.52 4.76 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.37 -1.287 . . . . 0.0 114.227 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -143.91 159.52 42.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 42' ' ' GLU . 13.8 t -118.97 133.22 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.891 0 CA-C-N 119.514 1.052 . . . . 0.0 109.244 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -122.77 -26.25 4.51 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 126.001 2.063 . . . . 0.0 111.936 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 79.1 m95 -157.01 137.01 12.6 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.893 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 12.0 t80 -121.38 121.85 38.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.453 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.05 171.63 13.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 p 65.84 146.51 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.402 0.62 . . . . 0.0 109.886 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -64.92 -16.01 62.76 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 18.9 mttt -105.76 -126.59 0.24 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.676 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -111.0 74.5 0.21 Allowed Glycine 0 C--N 1.345 1.072 0 C-N-CA 119.22 -1.467 . . . . 0.0 116.356 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 35.5 t80 -113.87 159.73 19.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 118.434 1.117 . . . . 0.0 108.078 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.28 -152.66 24.49 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.764 -1.208 . . . . 0.0 115.199 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 13.8 m-85 -133.18 144.19 49.69 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.654 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -132.2 157.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.354 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 23' ' ' GLY . 77.5 m -121.8 119.01 30.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.694 0.679 . . . . 0.0 110.314 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -65.69 142.86 57.88 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.668 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 19' ' ' LYS . 44.1 t0 -4.63 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.649 1.18 . . . . 0.0 113.86 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -115.73 31.76 6.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.79 -106.88 3.08 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.72 -142.42 4.62 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 121.569 -0.348 . . . . 0.0 112.382 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 12.1 p-10 -118.86 161.92 19.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.667 0.746 . . . . 0.0 111.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.654 HG12 ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -129.67 -177.11 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.741 -179.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.601 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.9 m-85 -129.3 155.99 44.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.897 -1.956 . . . . 0.0 106.423 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -148.34 138.97 17.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.462 ' CE1' ' CZ2' ' A' ' 29' ' ' TRP . 9.0 t-160 -92.19 -47.71 7.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.676 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 1.1 p90 142.78 -2.1 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.409 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 t -114.65 21.45 14.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 124.519 1.137 . . . . 0.0 109.2 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.893 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.422 -1.836 0 CA-C-O 121.343 0.592 . . . . 0.0 110.155 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -5.18 55.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.712 ' HA ' HG12 ' A' ' 5' ' ' VAL . 5.7 mt-10 82.17 -7.52 1.33 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.55 76.24 0.3 Allowed Glycine 0 N--CA 1.459 0.228 0 CA-C-O 119.482 -0.621 . . . . 0.0 112.926 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.625 ' OE1' HG22 ' A' ' 64' ' ' VAL . 27.5 pt20 -164.83 -162.07 0.61 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.327 1.063 . . . . 0.0 111.244 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.83 HG12 ' CG2' ' A' ' 65' ' ' VAL . 86.9 t -125.15 132.04 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.92 176.03 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.975 -175.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 17.5 tp10 -116.41 97.17 5.88 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -139.84 171.39 14.28 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -174.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.3 tm-20 -110.02 151.56 27.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.373 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.64 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -146.88 112.62 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.873 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 C--N 1.332 -0.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.07 -179.722 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.598 ' O ' HG22 ' A' ' 25' ' ' VAL . 83.5 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 CA-C-O 120.69 0.204 . . . . 0.0 112.526 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 5.0 tt0 -130.23 156.83 43.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.471 0.653 . . . . 0.0 111.025 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.719 ' HB1' ' CG2' ' A' ' 62' ' ' VAL . . . -67.89 129.29 39.46 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.324 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.78 -33.23 6.81 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.675 0.75 . . . . 0.0 110.127 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 4.0 m-70 -130.06 117.66 20.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.719 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 60.2 t -129.78 102.65 7.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.797 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.5 mttt -109.72 -172.54 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.625 HG22 ' OE1' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -121.05 146.65 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.83 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -152.52 175.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.686 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.84 179.677 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.441 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 3.9 ttp . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -163.79 140.12 6.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.758 0.789 . . . . 0.0 112.108 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.836 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.67 -134.47 3.13 Favored Glycine 0 C--O 1.22 -0.757 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.488 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 30.2 mttp -137.68 163.86 30.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 42' ' ' GLU . 12.8 t -123.81 134.77 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.93 -27.46 4.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 126.159 2.162 . . . . 0.0 112.377 -178.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 78.3 m95 -156.82 138.27 13.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.874 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 27.4 t80 -122.15 86.84 2.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' TYR . 3.3 t70 -89.5 166.38 13.72 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.854 -0.529 . . . . 0.0 110.049 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 1.2 t 64.1 145.03 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.685 0.755 . . . . 0.0 111.051 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -66.15 -16.37 63.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 27.3 mmtt -100.45 -140.31 0.33 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.683 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -98.93 70.26 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.112 -1.518 . . . . 0.0 115.274 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.456 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 t80 -113.86 148.29 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.06 -155.31 26.26 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 119.634 -1.27 . . . . 0.0 115.124 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 11.9 m-85 -132.83 139.48 47.5 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.322 -0.939 . . . . 0.0 109.437 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.619 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.25 148.78 31.03 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.417 -178.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 23' ' ' GLY . 72.8 m -121.02 115.62 23.5 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.347 -0.846 . . . . 0.0 109.893 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -63.71 157.22 24.75 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.776 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -23.95 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 45.48 1.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.429 0.633 . . . . 0.0 111.092 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 -115.31 2.76 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.16 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.817 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.29 -146.94 5.52 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.5 p30 -116.05 158.57 22.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.513 0.673 . . . . 0.0 111.042 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -124.32 178.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 122.625 1.202 . . . . 0.0 111.815 -177.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.56 ' N ' HG13 ' A' ' 25' ' ' VAL . 9.1 m-85 -131.65 131.46 43.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.077 -2.328 . . . . 0.0 105.092 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' GLY . 1.6 m -121.15 148.72 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 8.0 t-160 -95.8 -46.16 6.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.683 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 139.69 -4.01 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 124.119 0.968 . . . . 0.0 111.048 -177.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.33 21.07 14.99 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 124.67 1.231 . . . . 0.0 109.292 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.647 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.874 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 122.202 1.001 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.458 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -81.46 -5.89 58.39 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.231 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.758 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.5 OUTLIER 77.87 -5.05 2.16 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.6 52.85 0.59 Allowed Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.897 -0.391 . . . . 0.0 112.669 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.2 mt-30 -143.52 -164.47 1.87 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.426 0.613 . . . . 0.0 110.937 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' A' ' 65' ' ' VAL . 79.5 t -119.62 131.12 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.17 171.97 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 3.4 tt0 -115.97 95.43 5.1 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.62 ' CE1' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -136.43 173.27 11.89 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -174.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -126.24 137.66 53.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.06 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -130.73 126.03 59.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.097 0.475 . . . . 0.0 112.035 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 . . . . . 0 C--O 1.233 0.235 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.028 -179.742 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 N--CA 1.461 -0.387 0 N-CA-C 113.0 0.346 . . . . 0.0 113.0 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.617 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -130.95 158.72 39.49 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -67.81 126.86 30.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.324 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.57 -27.67 10.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.402 0.62 . . . . 0.0 111.536 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.508 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 1.5 m-70 -128.65 115.91 18.77 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.647 HG23 ' HB1' ' A' ' 31' ' ' ALA . 51.3 t -126.97 109.54 20.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.815 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.7 mttp -113.96 -178.64 3.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.644 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.96 146.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.13 0.877 . . . . 0.0 112.941 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.5 m -152.12 175.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.311 -1.095 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.944 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 4.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -162.31 137.65 7.18 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.787 0.803 . . . . 0.0 111.732 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.85 -117.46 1.44 Allowed Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.183 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 45' ' ' VAL . 14.7 mtmt -158.6 169.74 23.73 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.013 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -120.6 138.94 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.771 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HD3' ' CD1' ' A' ' 7' ' ' TRP . 13.5 ptpt -122.98 -30.29 3.8 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 126.443 2.34 . . . . 0.0 112.16 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.435 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 63.0 m95 -152.02 128.38 10.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.642 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 35.8 t80 -115.48 120.63 40.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.805 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.87 174.26 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.41 ' CB ' ' CB ' ' A' ' 14' ' ' TYR . 7.6 t 64.6 147.18 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.54 0.686 . . . . 0.0 110.337 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -15.96 62.59 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.777 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' A' ' 29' ' ' TRP . 18.7 mttt -105.64 -140.66 0.37 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -100.46 80.15 0.46 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 15.9 t80 -117.49 154.25 31.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.7 -154.4 25.81 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 119.748 -1.215 . . . . 0.0 115.052 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -133.18 138.03 46.43 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.272 -0.964 . . . . 0.0 109.897 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.769 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -122.12 161.41 22.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.496 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 23' ' ' GLY . 91.5 m -125.39 118.95 27.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.124 0.874 . . . . 0.0 110.778 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' ASP . 5.9 ptpt -67.2 144.8 55.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.509 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' LYS . 15.4 t70 -5.76 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.819 1.248 . . . . 0.0 114.1 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.33 31.04 6.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.79 -109.54 3.18 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.769 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.787 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.36 -146.57 5.45 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 9.9 p-10 -119.21 150.3 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.828 0.823 . . . . 0.0 112.223 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.769 HG12 ' HB ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -114.9 -173.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.541 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.594 ' N ' HG13 ' A' ' 25' ' ' VAL . 6.0 m-85 -127.7 162.1 27.36 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.424 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 13' ' ' GLY . 0.7 OUTLIER -156.43 143.51 10.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.442 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -105.51 -47.65 3.87 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -174.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.561 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 46.3 p-90 165.68 -25.96 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.09 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 1.1 p -117.79 30.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 124.669 1.231 . . . . 0.0 107.916 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.694 0 CA-C-N 113.659 -1.609 . . . . 0.0 108.494 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.642 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.427 -1.585 0 CA-C-O 121.806 0.813 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.48 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.43 -12.79 59.52 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.501 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 7' ' ' TRP . 0.3 OUTLIER 69.69 2.09 3.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.81 54.76 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.3 mt-30 -145.62 -164.47 1.96 Allowed 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 117.256 0.528 . . . . 0.0 110.405 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.87 HG12 ' CG2' ' A' ' 65' ' ' VAL . 79.2 t -118.52 128.12 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -113.55 171.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.07 93.39 4.16 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -135.92 170.85 15.34 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -123.41 136.58 54.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.236 0.349 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.852 -179.878 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' O ' HG22 ' A' ' 25' ' ' VAL . 85.0 Cg_endo . . . . . 0 N--CA 1.461 -0.413 0 N-CA-C 111.362 -0.284 . . . . 0.0 111.362 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.555 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -131.62 151.03 51.93 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.942 0.877 . . . . 0.0 112.327 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.811 ' O ' ' HB1' ' A' ' 31' ' ' ALA . . . -68.93 151.13 46.94 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.541 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.0 -37.17 2.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.664 0.745 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.6 m-70 -129.13 115.35 17.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.715 HG13 HG11 ' A' ' 46' ' ' VAL . 69.6 t -128.83 135.66 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.0 112.039 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.802 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -130.5 -175.95 3.81 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.61 135.94 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.648 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.87 ' CG2' HG12 ' A' ' 45' ' ' VAL . 2.5 m -142.76 177.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.836 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.975 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.875 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 47' ' ' GLU . 47.4 mtt180 -158.49 142.21 15.32 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.801 0.81 . . . . 0.0 113.133 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.762 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -140.72 -146.97 4.87 Favored Glycine 0 CA--C 1.497 -1.082 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.522 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 1.4 mttt -136.6 163.91 29.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 42' ' ' GLU . 17.3 t -119.28 133.49 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.755 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 4.0 pttt -121.86 -29.47 4.29 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 126.007 2.067 . . . . 0.0 112.997 -175.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 67.3 m95 -153.41 141.04 19.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 20.4 t80 -120.83 137.88 54.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.129 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 7.8 m-20 -134.22 120.9 20.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.421 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 1.8 m 60.11 154.61 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 122.05 0.929 . . . . 0.0 111.963 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -64.42 -29.76 70.82 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 14' ' ' TYR . 43.8 mmtt -75.13 94.72 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.637 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -17.16 74.45 0.0 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.2 t80 -115.49 150.71 36.08 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.54 -160.07 28.57 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 119.437 -1.363 . . . . 0.0 115.075 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.14 129.55 38.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.009 -1.095 . . . . 0.0 110.11 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.848 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -112.9 171.08 3.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.571 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 23' ' ' GLY . 97.1 m -121.24 125.22 46.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 110.135 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -65.52 118.6 9.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' ' HA2' ' A' ' 3' ' ' GLY . 27.6 t70 36.2 -88.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.796 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.3 pp20? -118.96 -36.47 3.41 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.74 -13.13 5.21 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 18' ' ' THR . . . -87.63 -174.95 48.44 Favored Glycine 0 C--N 1.323 -0.165 0 C-N-CA 119.577 -1.297 . . . . 0.0 112.763 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.7 m-20 -154.47 135.65 13.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.534 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.92 HG21 HG22 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -119.67 -177.75 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 122.407 1.099 . . . . 0.0 111.838 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.611 ' N ' HG13 ' A' ' 25' ' ' VAL . 17.1 m-85 -130.95 164.61 24.94 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.61 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' GLY . 1.6 m -148.69 147.27 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.487 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -96.26 -57.09 2.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.637 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 170.25 -30.31 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.967 -0.458 . . . . 0.0 111.579 -178.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -118.23 29.78 7.59 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 124.936 1.397 . . . . 0.0 107.959 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . . . . . . 0 N--CA 1.439 -0.995 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.302 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.628 ' HB3' HG11 ' A' ' 5' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.429 -1.485 0 CA-C-O 121.787 0.803 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.447 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -93.01 -10.09 37.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.173 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 75.16 -2.1 2.91 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.89 56.82 0.55 Allowed Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.126 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.1 mt-30 -143.94 -167.13 2.52 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 117.879 0.84 . . . . 0.0 111.105 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.851 HG12 ' CG2' ' A' ' 65' ' ' VAL . 85.0 t -122.18 129.63 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.21 175.65 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.082 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.28 96.83 5.6 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -143.98 173.39 11.76 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 117.63 2.455 . . . . 0.0 117.63 -175.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.4 148.79 41.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.92 HG22 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -140.54 120.45 12.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.834 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 . . . . . 0 C--O 1.235 0.334 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.782 179.844 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo . . . . . 0 C--O 1.23 0.119 0 N-CA-C 111.562 -0.207 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.648 ' HA ' HG22 ' A' ' 25' ' ' VAL . 1.8 tt0 -132.73 151.63 51.93 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.859 0.838 . . . . 0.0 112.75 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.69 ' HB2' HG11 ' A' ' 25' ' ' VAL . . . -70.09 145.7 51.44 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 113.847 -1.524 . . . . 0.0 107.271 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.38 -34.16 3.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.515 0.674 . . . . 0.0 111.108 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 5.8 m-70 -129.04 113.14 14.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.752 HG13 HG11 ' A' ' 46' ' ' VAL . 77.0 t -128.93 139.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.782 0.801 . . . . 0.0 112.454 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.809 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 mttm -135.9 -172.75 3.19 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.76 144.36 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.328 0.967 . . . . 0.0 113.193 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.851 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -151.67 174.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.466 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--N 1.31 -1.15 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.943 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 13.6 mmt . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 47' ' ' GLU . 48.9 mtt85 -158.95 138.53 11.69 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.977 0.894 . . . . 0.0 113.123 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.32 -134.17 3.12 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 114.167 -1.378 . . . . 0.0 113.151 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 17' ' ' ILE . 2.0 ttmm -159.33 167.53 28.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.595 ' CG1' HD12 ' A' ' 40' ' ' LEU . 1.6 t -117.51 130.81 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.194 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 16' ' ' PHE . 8.0 ptmt -123.48 -38.25 2.56 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 126.116 2.135 . . . . 0.0 112.726 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.427 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 78.3 m95 -141.44 135.45 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.566 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CE1' HD23 ' A' ' 40' ' ' LEU . 14.8 t80 -120.43 133.8 55.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.306 0.574 . . . . 0.0 112.353 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 4.6 m-20 -133.76 136.37 44.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.233 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' CZ ' ' A' ' 8' ' ' PHE . 10.0 t 60.97 146.47 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.953 0.882 . . . . 0.0 111.905 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mppp? -66.66 -12.71 59.42 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.787 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 29' ' ' TRP . 2.8 mmtp -100.58 105.02 16.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.641 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -10.46 70.27 0.0 OUTLIER Glycine 0 CA--C 1.531 1.064 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -118.07 141.96 47.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 -147.87 17.51 Favored Glycine 0 CA--C 1.501 -0.828 0 C-N-CA 118.794 -1.669 . . . . 0.0 115.768 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 26' ' ' PHE . 3.9 m-85 -132.98 145.54 50.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.157 -1.021 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.674 HD11 HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -130.88 159.11 43.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.103 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.804 HG23 ' O ' ' A' ' 23' ' ' GLY . 97.4 m -123.91 118.6 27.44 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.628 1.104 . . . . 0.0 111.643 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.14 130.08 41.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.764 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.5 t0 9.04 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.335 1.454 . . . . 0.0 113.997 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.38 24.89 11.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.47 0.176 . . . . 0.0 111.197 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.88 -107.41 2.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.487 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.804 ' O ' HG23 ' A' ' 18' ' ' THR . . . -133.63 -143.89 5.04 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -118.37 163.29 16.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.621 0.724 . . . . 0.0 111.853 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -127.24 -175.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.785 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.585 ' N ' HG13 ' A' ' 25' ' ' VAL . 55.6 m-85 -128.55 157.71 40.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.928 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.674 HG11 HD11 ' A' ' 17' ' ' ILE . 1.8 m -149.19 148.95 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.963 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -89.88 -61.3 1.72 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -174.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 17.8 p-90 169.32 -27.86 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 121.969 -0.457 . . . . 0.0 111.687 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.457 ' CB ' ' CE3' ' A' ' 29' ' ' TRP . 10.2 t -118.9 32.47 6.12 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . . . . . . 0 N--CA 1.438 -1.035 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.331 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.818 HD23 ' CE1' ' A' ' 8' ' ' PHE . 2.1 mm? . . . . . 0 N--CA 1.414 -2.257 0 CA-C-O 122.328 1.061 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 1.4 mmtt -78.12 -6.49 54.89 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.48 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.467 ' HA ' HG12 ' A' ' 5' ' ' VAL . 15.9 pm0 53.93 15.28 0.82 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.348 0.659 . . . . 0.0 112.585 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.78 49.8 0.67 Allowed Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 7.0 mt-30 -144.4 -168.87 3.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 117.85 0.825 . . . . 0.0 111.663 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.831 HG12 ' CG2' ' A' ' 65' ' ' VAL . 74.8 t -120.67 130.15 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.896 HG11 HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -113.93 176.49 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.583 -174.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 1.8 tt0 -117.7 96.62 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -145.26 167.87 21.79 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -175.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -121.24 146.13 47.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.089 -1.869 . . . . 0.0 106.372 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.661 HG21 HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -140.24 136.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.719 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.669 ' O ' HG22 ' A' ' 25' ' ' VAL . 94.4 Cg_endo . . . . . 0 N--CA 1.461 -0.433 0 N-CA-C 112.791 0.266 . . . . 0.0 112.791 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.488 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 2.1 tt0 -130.5 152.49 49.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 111.083 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.67 ' HB1' ' CG2' ' A' ' 62' ' ' VAL . . . -69.54 138.46 53.29 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.013 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.95 -38.3 2.97 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.826 0.822 . . . . 0.0 109.792 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 17.7 m-70 -129.77 110.79 12.03 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.896 HG13 HG11 ' A' ' 46' ' ' VAL . 87.5 t -127.95 139.06 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.444 0.64 . . . . 0.0 111.666 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.3 mttp -134.46 -171.15 2.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.81 144.2 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.303 0.956 . . . . 0.0 113.175 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.831 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.5 m -151.36 175.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.491 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 . . . . . 0 C--N 1.309 -1.164 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.869 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 10.1 ttt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -164.29 145.63 8.46 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.995 0.903 . . . . 0.0 112.096 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.855 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -141.66 -135.89 3.19 Favored Glycine 0 C--O 1.218 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 114.199 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 5.1 mttt -135.99 161.73 34.85 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.785 HG12 ' HA ' ' A' ' 42' ' ' GLU . 14.1 t -121.88 135.7 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.785 0 CA-C-N 119.208 0.913 . . . . 0.0 108.71 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.61 -28.5 4.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.422 2.326 . . . . 0.0 112.764 -177.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.43 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 70.6 m95 -156.85 134.65 10.93 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.892 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 25.9 t80 -121.08 126.21 49.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.198 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -132.27 174.19 10.48 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.4 t 62.56 146.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.893 0.854 . . . . 0.0 111.165 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -65.94 -15.98 63.46 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.757 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 4.4 mptt -105.39 -137.27 0.36 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.692 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -100.62 72.91 0.42 Allowed Glycine 0 CA--C 1.525 0.664 0 C-N-CA 119.703 -1.237 . . . . 0.0 115.657 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 27' ' ' VAL . 13.3 t80 -113.07 153.54 28.0 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.34 -157.65 27.41 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 119.699 -1.238 . . . . 0.0 115.527 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -133.17 136.81 45.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.364 -0.918 . . . . 0.0 110.075 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.822 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -124.22 168.23 17.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.437 -178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.832 HG23 ' O ' ' A' ' 23' ' ' GLY . 63.7 m -125.08 123.48 39.84 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -69.19 141.99 54.39 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.577 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 19' ' ' LYS . 30.2 t0 -2.39 -91.26 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -116.16 29.93 7.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.675 0.274 . . . . 0.0 110.954 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -101.01 -111.07 3.36 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.967 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.832 ' O ' HG23 ' A' ' 18' ' ' THR . . . -132.61 -141.37 4.63 Favored Glycine 0 C--O 1.219 -0.832 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 3.3 p30 -119.59 145.42 46.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 122.096 0.95 . . . . 0.0 112.933 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.083 HG21 HD12 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -114.28 -173.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.87 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.613 ' N ' HG13 ' A' ' 25' ' ' VAL . 12.5 m-85 -130.6 164.93 23.87 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 113.483 -1.689 . . . . 0.0 107.672 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.073 HG21 HD11 ' A' ' 32' ' ' ILE . 1.4 m -148.9 145.69 17.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.43 ' O ' ' CD1' ' A' ' 29' ' ' TRP . 2.7 t-160 -98.25 -47.48 5.44 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.681 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 27.0 p-90 146.16 -11.45 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 124.528 1.131 . . . . 0.0 109.73 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -113.13 25.64 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 124.057 0.848 . . . . 0.0 109.22 177.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -121.27 -29.8 4.42 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.073 HD11 HG21 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -114.8 61.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.661 0 CA-C-O 123.365 1.555 . . . . 0.0 108.173 176.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 1.1 mm-40 -124.34 84.01 2.22 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 111.989 -2.368 . . . . 0.0 110.643 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.3 175.63 6.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -122.91 21.05 9.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.746 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.89 -61.94 0.32 Allowed Glycine 0 C--N 1.33 0.25 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -164.29 94.56 0.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.065 0.46 . . . . 0.0 109.998 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.813 ' CG ' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -126.18 130.19 50.48 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.206 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -172.65 -32.53 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.892 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER 60.69 112.35 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.036 0.922 . . . . 0.0 110.702 -177.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.531 ' HE3' HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -80.95 -4.59 55.52 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.069 178.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.785 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER 76.29 -0.56 3.07 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 178.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.56 42.68 1.01 Allowed Glycine 0 N--CA 1.463 0.493 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.241 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.5 mt-30 -138.86 -162.01 1.26 Allowed 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 117.382 0.591 . . . . 0.0 111.359 -176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.924 HG12 ' CG2' ' A' ' 65' ' ' VAL . 69.8 t -119.58 132.1 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.834 HG22 ' O ' ' A' ' 63' ' ' LYS . 1.0 OUTLIER -113.96 172.66 3.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -116.29 96.77 5.7 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.711 ' CE2' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -140.1 177.8 7.72 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -174.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -132.86 158.16 43.22 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.411 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.083 HD12 HG21 ' A' ' 25' ' ' VAL . 5.5 mm -138.66 142.06 35.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.293 0.568 . . . . 0.0 112.131 -178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -131.03 133.58 45.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.598 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -117.18 130.5 56.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -129.77 -124.69 2.65 Favored Glycine 0 CA--C 1.508 -0.35 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.477 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -25.24 64.2 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.471 -0.364 . . . . 0.0 110.931 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -106.13 -127.36 0.25 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.197 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.75 166.48 12.16 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.452 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 25' ' ' VAL . 11.0 Cg_exo -70.74 127.14 13.43 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.527 2.152 . . . . 0.0 112.184 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.493 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 5.7 tt0 -129.76 153.64 48.0 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.329 0.585 . . . . 0.0 111.075 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.894 ' HA ' HD13 ' A' ' 50' ' ' ILE . . . -68.03 134.21 50.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.813 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.07 -30.22 7.06 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.482 0.658 . . . . 0.0 111.071 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 11.0 m-70 -129.39 117.75 21.09 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.557 HG23 ' HB1' ' A' ' 31' ' ' ALA . 37.4 t -132.36 115.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -175.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.834 ' O ' HG22 ' A' ' 46' ' ' VAL . 9.7 mtpt -118.97 -175.51 2.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.531 HG21 ' HE3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -120.83 146.6 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 119.171 0.896 . . . . 0.0 113.068 -178.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.924 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -152.1 175.04 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.655 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--N 1.309 -1.184 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.917 179.804 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.9 mmt . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HD2' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -161.4 138.91 8.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.901 0.858 . . . . 0.0 111.092 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.653 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -140.06 -120.38 1.73 Allowed Glycine 0 CA--C 1.501 -0.82 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.561 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.6 ttmt -158.38 167.41 29.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-N 114.346 -0.927 . . . . 0.0 108.709 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.855 ' CG1' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -120.85 138.13 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.024 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -123.93 -32.58 3.25 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 126.684 2.49 . . . . 0.0 112.113 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 70.1 m95 -152.07 139.4 19.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.78 ' CE1' HD23 ' A' ' 40' ' ' LEU . 4.6 t80 -123.24 126.28 46.64 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.411 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.89 167.26 20.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 122.413 0.285 . . . . 0.0 110.323 178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.457 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 0.9 OUTLIER 66.86 154.81 0.09 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.029 0.919 . . . . 0.0 111.522 178.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -66.35 -27.45 67.9 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.515 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 17.9 mmtt -94.5 -124.84 0.11 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.685 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -114.85 77.06 0.26 Allowed Glycine 0 C--N 1.345 1.039 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.939 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.457 ' HB2' ' CB ' ' A' ' 10' ' ' SER . 1.5 t80 -109.93 156.48 20.38 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 118.942 1.371 . . . . 0.0 109.606 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 7' ' ' TRP . . . 143.99 -148.82 20.75 Favored Glycine 0 CA--C 1.504 -0.639 0 C-N-CA 119.595 -1.288 . . . . 0.0 115.712 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 25' ' ' VAL . 12.1 m-85 -133.21 143.38 49.13 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.011 -1.094 . . . . 0.0 109.418 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -129.79 155.91 41.73 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.255 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.894 -178.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.813 HG23 ' O ' ' A' ' 23' ' ' GLY . 90.4 m -121.89 116.44 24.4 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.665 -0.647 . . . . 0.0 110.579 177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -65.76 145.56 55.84 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.456 -0.497 . . . . 0.0 109.763 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -6.91 -92.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.784 1.233 . . . . 0.0 114.043 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.12 31.16 6.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.625 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.93 -108.93 3.13 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.557 -0.83 . . . . 0.0 114.78 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.813 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.85 -145.64 5.23 Favored Glycine 0 C--O 1.22 -0.724 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.4 p30 -117.69 161.86 18.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.433 0.635 . . . . 0.0 111.555 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.65 HG22 ' O ' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -126.32 178.76 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 122.51 1.148 . . . . 0.0 111.54 -178.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.56 ' N ' HG13 ' A' ' 25' ' ' VAL . 84.4 t80 -130.83 128.19 40.15 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 112.274 -2.239 . . . . 0.0 106.074 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.639 HG21 HD11 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -121.33 143.77 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.393 -176.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.456 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 1.6 t60 -92.02 -21.85 20.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 117.39 2.367 . . . . 0.0 117.39 -174.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.685 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER 103.67 10.07 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 119.132 0.878 . . . . 0.0 111.082 -176.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.89 17.91 11.79 Favored 'General case' 0 N--CA 1.427 -1.615 0 O-C-N 124.901 1.375 . . . . 0.0 108.113 174.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.617 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -123.66 -29.63 3.71 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.793 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.953 ' CG2' HD21 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -115.53 59.21 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 123.497 1.618 . . . . 0.0 108.253 176.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -125.16 87.9 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 112.038 -2.346 . . . . 0.0 110.216 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.411 ' CB ' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -120.29 167.85 11.87 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.582 179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -121.98 19.0 10.9 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.45 -60.24 0.32 Allowed Glycine 0 CA--C 1.508 -0.349 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -165.05 80.68 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.007 -0.597 . . . . 0.0 109.708 177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' HG2' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -115.28 123.37 48.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.924 ' C ' HD22 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -162.91 164.06 26.04 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-O 122.581 1.182 . . . . 0.0 111.652 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.953 HD21 ' CG2' ' A' ' 32' ' ' ILE . 3.4 mm? -132.11 106.39 7.96 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 112.383 -2.19 . . . . 0.0 110.998 -175.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.14 -9.46 59.71 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.078 -1.874 . . . . 0.0 109.787 178.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 2.5 mp0 66.82 5.79 4.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.478 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.69 45.87 0.83 Allowed Glycine 0 CA--C 1.506 -0.508 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.011 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 3.3 mt-30 -141.49 -163.29 1.54 Allowed 'General case' 0 CA--C 1.499 -1.005 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.492 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.836 HG12 ' CG2' ' A' ' 65' ' ' VAL . 76.7 t -118.52 132.59 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.791 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.23 176.11 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -175.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 35.4 tp10 -120.29 91.56 3.57 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.656 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -138.69 167.57 21.69 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -175.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -120.94 149.38 42.72 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 113.428 -1.715 . . . . 0.0 107.083 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.656 HD12 ' CZ ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -142.99 125.37 12.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.394 -178.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -130.54 167.1 19.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.729 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -112.87 129.34 56.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.8 -132.49 3.84 Favored Glycine 0 CA--C 1.509 -0.32 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.7 mmmm -59.19 -28.22 66.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.958 0.409 . . . . 0.0 110.716 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -108.51 -124.91 0.25 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.045 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.08 -167.28 16.07 Favored Glycine 0 C--N 1.342 0.882 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.087 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.65 ' O ' HG22 ' A' ' 25' ' ' VAL . 7.0 Cg_exo -72.08 113.67 3.75 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.386 2.058 . . . . 0.0 112.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.545 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -128.65 152.22 48.61 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.794 0.806 . . . . 0.0 111.084 179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -68.45 136.71 53.66 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.029 -1.441 . . . . 0.0 109.179 177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.43 -30.94 6.97 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.521 0.677 . . . . 0.0 111.209 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 3.6 m-70 -129.49 116.23 18.65 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.796 ' CG1' HG23 ' A' ' 32' ' ' ILE . 38.4 t -131.93 119.54 41.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.791 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.0 OUTLIER -127.49 -177.72 4.19 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 177.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.11 141.99 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.986 0.812 . . . . 0.0 113.163 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.836 ' CG2' HG12 ' A' ' 45' ' ' VAL . 2.2 m -142.69 177.67 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.214 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.31 -1.143 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.957 179.911 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 89.7 mtm-85 -159.48 141.65 13.52 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 122.047 0.927 . . . . 0.0 113.21 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.778 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.16 -145.52 4.76 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-N 114.37 -1.287 . . . . 0.0 114.227 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -143.91 159.52 42.42 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 42' ' ' GLU . 13.8 t -118.97 133.22 66.52 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.891 0 CA-C-N 119.514 1.052 . . . . 0.0 109.244 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -122.77 -26.25 4.51 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 126.001 2.063 . . . . 0.0 111.936 -177.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 79.1 m95 -157.01 137.01 12.6 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.893 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 12.0 t80 -121.38 121.85 38.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.453 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.05 171.63 13.02 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.8 p 65.84 146.51 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.402 0.62 . . . . 0.0 109.886 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -64.92 -16.01 62.76 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 18.9 mttt -105.76 -126.59 0.24 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.726 ' HA3' ' HB ' ' A' ' 32' ' ' ILE . . . -111.0 74.5 0.21 Allowed Glycine 0 C--N 1.345 1.072 0 C-N-CA 119.22 -1.467 . . . . 0.0 116.356 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 35.5 t80 -113.87 159.73 19.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 118.434 1.117 . . . . 0.0 108.078 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.28 -152.66 24.49 Favored Glycine 0 CA--C 1.505 -0.558 0 C-N-CA 119.764 -1.208 . . . . 0.0 115.199 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.503 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 13.8 m-85 -133.18 144.19 49.69 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.434 -0.883 . . . . 0.0 109.848 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.654 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -132.2 157.95 43.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.354 -179.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.801 HG23 ' O ' ' A' ' 23' ' ' GLY . 77.5 m -121.8 119.01 30.43 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.694 0.679 . . . . 0.0 110.314 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -65.69 142.86 57.88 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.668 -179.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 19' ' ' LYS . 44.1 t0 -4.63 -92.59 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.649 1.18 . . . . 0.0 113.86 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -115.73 31.76 6.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.876 0.37 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.79 -106.88 3.08 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 115.317 0.887 . . . . 0.0 115.317 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.72 -142.42 4.62 Favored Glycine 0 C--O 1.218 -0.883 0 C-N-CA 121.569 -0.348 . . . . 0.0 112.382 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 12.1 p-10 -118.86 161.92 19.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.667 0.746 . . . . 0.0 111.868 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.654 HG12 ' HB ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -129.67 -177.11 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.741 -179.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.601 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.9 m-85 -129.3 155.99 44.72 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 112.897 -1.956 . . . . 0.0 106.423 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -148.34 138.97 17.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.462 ' CE1' ' CZ2' ' A' ' 29' ' ' TRP . 9.0 t-160 -92.19 -47.71 7.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 -173.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.676 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 1.1 p90 142.78 -2.1 0.0 OUTLIER 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 118.065 -0.969 . . . . 0.0 111.409 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.7 t -114.65 21.45 14.46 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 124.519 1.137 . . . . 0.0 109.2 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.678 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -121.45 -25.0 5.26 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -113.71 32.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-O 122.576 1.179 . . . . 0.0 109.776 177.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -119.61 93.5 4.09 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.163 -1.381 . . . . 0.0 112.666 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.484 ' HB2' ' CE ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -121.85 -170.51 2.06 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.245 178.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -120.18 28.52 8.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.123 0.487 . . . . 0.0 110.991 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.38 -100.41 2.19 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.39 78.12 0.36 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.223 0.535 . . . . 0.0 110.88 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' CE ' ' HB2' ' A' ' 34' ' ' MET . 0.0 OUTLIER -120.76 155.05 34.79 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 177.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -170.36 168.86 7.83 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.144 -176.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.893 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -120.93 114.18 21.18 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.155 -179.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -5.18 55.33 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.217 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.712 ' HA ' HG12 ' A' ' 5' ' ' VAL . 5.7 mt-10 82.17 -7.52 1.33 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.55 76.24 0.3 Allowed Glycine 0 N--CA 1.459 0.228 0 CA-C-O 119.482 -0.621 . . . . 0.0 112.926 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.625 ' OE1' HG22 ' A' ' 64' ' ' VAL . 27.5 pt20 -164.83 -162.07 0.61 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 118.327 1.063 . . . . 0.0 111.244 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.83 HG12 ' CG2' ' A' ' 65' ' ' VAL . 86.9 t -125.15 132.04 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.92 176.03 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.975 -175.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 17.5 tp10 -116.41 97.17 5.88 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -139.84 171.39 14.28 Favored 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 -174.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.3 tm-20 -110.02 151.56 27.02 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.373 177.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.64 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -146.88 112.62 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.873 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.61 136.04 49.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.07 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -109.94 153.16 24.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.105 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.16 -116.06 2.05 Favored Glycine 0 CA--C 1.506 -0.489 0 C-N-CA 120.911 -0.661 . . . . 0.0 111.76 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -28.37 65.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.511 -0.344 . . . . 0.0 110.426 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.25 -114.34 0.31 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.85 -179.09 18.78 Favored Glycine 0 C--N 1.344 1.022 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.713 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.598 ' O ' HG22 ' A' ' 25' ' ' VAL . 83.5 Cg_endo -82.65 141.38 10.97 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.633 2.222 . . . . 0.0 112.526 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 5.0 tt0 -130.23 156.83 43.96 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.471 0.653 . . . . 0.0 111.025 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.719 ' HB1' ' CG2' ' A' ' 62' ' ' VAL . . . -67.89 129.29 39.46 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.324 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.78 -33.23 6.81 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.675 0.75 . . . . 0.0 110.127 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 4.0 m-70 -130.06 117.66 20.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.719 ' CG2' ' HB1' ' A' ' 59' ' ' ALA . 60.2 t -129.78 102.65 7.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -175.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.797 ' O ' HG22 ' A' ' 46' ' ' VAL . 1.5 mttt -109.72 -172.54 2.06 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.625 HG22 ' OE1' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -121.05 146.65 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.83 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -152.52 175.04 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.686 178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.84 179.677 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' CA ' ' O ' ' A' ' 48' ' ' PHE . 3.9 ttp . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -163.79 140.12 6.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.758 0.789 . . . . 0.0 112.108 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.836 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.67 -134.47 3.13 Favored Glycine 0 C--O 1.22 -0.757 0 CA-C-N 115.101 -0.954 . . . . 0.0 114.488 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 30.2 mttp -137.68 163.86 30.26 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 42' ' ' GLU . 12.8 t -123.81 134.77 65.54 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.597 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -121.93 -27.46 4.62 Favored 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 126.159 2.162 . . . . 0.0 112.377 -178.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' A' ' 6' ' ' LYS . 78.3 m95 -156.82 138.27 13.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.874 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 27.4 t80 -122.15 86.84 2.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.948 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' TYR . 3.3 t70 -89.5 166.38 13.72 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.854 -0.529 . . . . 0.0 110.049 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 14' ' ' TYR . 1.2 t 64.1 145.03 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 121.685 0.755 . . . . 0.0 111.051 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -66.15 -16.37 63.91 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.165 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 29' ' ' TRP . 27.3 mmtt -100.45 -140.31 0.33 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.683 ' C ' ' HA ' ' A' ' 29' ' ' TRP . . . -98.93 70.26 0.57 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 119.112 -1.518 . . . . 0.0 115.274 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.456 ' O ' ' N ' ' A' ' 9' ' ' ASP . 1.5 t80 -113.86 148.29 36.93 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.06 -155.31 26.26 Favored Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 119.634 -1.27 . . . . 0.0 115.124 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CZ ' ' CE2' ' A' ' 26' ' ' PHE . 11.9 m-85 -132.83 139.48 47.5 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.322 -0.939 . . . . 0.0 109.437 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.619 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.25 148.78 31.03 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.13 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.417 -178.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 23' ' ' GLY . 72.8 m -121.02 115.62 23.5 Favored 'General case' 0 C--O 1.215 -0.742 0 O-C-N 121.347 -0.846 . . . . 0.0 109.893 177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -63.71 157.22 24.75 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.776 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -23.95 -87.76 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.56 45.48 1.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.429 0.633 . . . . 0.0 111.092 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.35 -115.31 2.76 Favored Glycine 0 C--N 1.318 -0.453 0 CA-C-N 115.493 -0.776 . . . . 0.0 114.16 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.817 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.29 -146.94 5.52 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 2.5 p30 -116.05 158.57 22.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.513 0.673 . . . . 0.0 111.042 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -124.32 178.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 122.625 1.202 . . . . 0.0 111.815 -177.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.56 ' N ' HG13 ' A' ' 25' ' ' VAL . 9.1 m-85 -131.65 131.46 43.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 112.077 -2.328 . . . . 0.0 105.092 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.886 HG21 HD11 ' A' ' 32' ' ' ILE . 1.6 m -121.15 148.72 24.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.47 ' O ' ' CB ' ' A' ' 29' ' ' TRP . 8.0 t-160 -95.8 -46.16 6.69 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.683 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 139.69 -4.01 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.429 0 C-N-CA 124.119 0.968 . . . . 0.0 111.048 -177.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -114.33 21.07 14.99 Favored 'General case' 0 N--CA 1.426 -1.653 0 O-C-N 124.67 1.231 . . . . 0.0 109.292 177.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.647 ' HB1' HG23 ' A' ' 62' ' ' VAL . . . -121.64 -24.26 5.36 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 27' ' ' VAL . 0.3 OUTLIER -114.3 41.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.69 0 CA-C-O 122.841 1.305 . . . . 0.0 109.72 177.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -114.38 90.79 3.43 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.878 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.11 -175.58 3.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -122.07 23.03 10.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.961 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -117.23 -74.18 0.51 Allowed Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -164.86 76.46 0.29 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.804 0.335 . . . . 0.0 110.851 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -116.05 111.09 19.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.549 0.69 . . . . 0.0 110.304 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.499 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -147.79 -24.07 0.37 Allowed 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.964 -176.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.874 ' HB2' ' CD1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER 61.86 118.14 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 122.202 1.001 . . . . 0.0 110.741 -178.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -81.46 -5.89 58.39 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.231 178.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.758 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.5 OUTLIER 77.87 -5.05 2.16 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.6 52.85 0.59 Allowed Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.897 -0.391 . . . . 0.0 112.669 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 2.2 mt-30 -143.52 -164.47 1.87 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 117.426 0.613 . . . . 0.0 110.937 -176.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' A' ' 65' ' ' VAL . 79.5 t -119.62 131.12 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.17 171.97 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 3.4 tt0 -115.97 95.43 5.1 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.62 ' CE1' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -136.43 173.27 11.89 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -174.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -126.24 137.66 53.55 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 113.819 -1.537 . . . . 0.0 108.06 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.642 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -130.73 126.03 59.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.097 0.475 . . . . 0.0 112.035 -178.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -129.63 140.75 51.08 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.028 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HB3' ' N ' ' A' ' 57' ' ' PRO . 6.6 pt-20 -112.41 163.15 14.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.609 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.02 -111.76 1.5 Allowed Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -81.92 -25.0 35.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.164 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -110.03 -125.18 0.27 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.541 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.26 166.82 13.98 Favored Glycine 0 C--N 1.344 0.996 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.411 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' N ' ' HB3' ' A' ' 52' ' ' GLU . 94.4 Cg_endo -85.15 147.12 10.19 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.446 2.097 . . . . 0.0 113.0 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.617 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -130.95 158.72 39.49 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' N ' ' HG2' ' A' ' 58' ' ' GLN . . . -67.81 126.86 30.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.324 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.57 -27.67 10.23 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.402 0.62 . . . . 0.0 111.536 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.508 ' O ' ' HB2' ' A' ' 48' ' ' PHE . 1.5 m-70 -128.65 115.91 18.77 Favored 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.647 HG23 ' HB1' ' A' ' 31' ' ' ALA . 51.3 t -126.97 109.54 20.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.815 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.7 mttp -113.96 -178.64 3.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.644 178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.96 146.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 119.13 0.877 . . . . 0.0 112.941 -179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.5 m -152.12 175.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.596 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--N 1.311 -1.095 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.944 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 4.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -162.31 137.65 7.18 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.787 0.803 . . . . 0.0 111.732 -178.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.803 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.85 -117.46 1.44 Allowed Glycine 0 CA--C 1.499 -0.926 0 CA-C-N 114.781 -1.099 . . . . 0.0 113.183 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.82 ' HG2' HG22 ' A' ' 45' ' ' VAL . 14.7 mtmt -158.6 169.74 23.73 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 114.973 -0.613 . . . . 0.0 110.013 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.638 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -120.6 138.94 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.771 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HD3' ' CD1' ' A' ' 7' ' ' TRP . 13.5 ptpt -122.98 -30.29 3.8 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 126.443 2.34 . . . . 0.0 112.16 -177.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.435 ' CD1' ' HD3' ' A' ' 6' ' ' LYS . 63.0 m95 -152.02 128.38 10.6 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.652 ' HE1' HD12 ' A' ' 32' ' ' ILE . 35.8 t80 -115.48 120.63 40.14 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.805 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.87 174.26 10.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.41 ' CB ' ' CB ' ' A' ' 14' ' ' TYR . 7.6 t 64.6 147.18 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 121.54 0.686 . . . . 0.0 110.337 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -15.96 62.59 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.777 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.409 ' HB2' ' CB ' ' A' ' 29' ' ' TRP . 18.7 mttt -105.64 -140.66 0.37 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 27' ' ' VAL . . . -100.46 80.15 0.46 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.348 -0.929 . . . . 0.0 113.845 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' A' ' 15' ' ' GLY . 15.9 t80 -117.49 154.25 31.75 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 14' ' ' TYR . . . 144.7 -154.4 25.81 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 119.748 -1.215 . . . . 0.0 115.052 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.4 m-30 -133.18 138.03 46.43 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.272 -0.964 . . . . 0.0 109.897 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.769 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -122.12 161.41 22.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.496 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 23' ' ' GLY . 91.5 m -125.39 118.95 27.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.124 0.874 . . . . 0.0 110.778 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 20' ' ' ASP . 5.9 ptpt -67.2 144.8 55.78 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.509 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 19' ' ' LYS . 15.4 t70 -5.76 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.819 1.248 . . . . 0.0 114.1 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -115.33 31.04 6.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.529 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.79 -109.54 3.18 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.769 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.787 ' O ' HG23 ' A' ' 18' ' ' THR . . . -134.36 -146.57 5.45 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 9.9 p-10 -119.21 150.3 40.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.828 0.823 . . . . 0.0 112.223 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.769 HG12 ' HB ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER -114.9 -173.88 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.541 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.594 ' N ' HG13 ' A' ' 25' ' ' VAL . 6.0 m-85 -127.7 162.1 27.36 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.424 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.66 HG21 HD11 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -156.43 143.51 10.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.442 ' HA ' ' CD2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -105.51 -47.65 3.87 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -174.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.561 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 46.3 p-90 165.68 -25.96 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.09 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 1.1 p -117.79 30.53 7.21 Favored 'General case' 0 N--CA 1.44 -0.961 0 O-C-N 124.669 1.231 . . . . 0.0 107.916 176.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.811 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . -133.31 28.08 4.08 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 113.659 -1.609 . . . . 0.0 108.494 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.837 HG23 HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -121.68 -95.86 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 32' ' ' ILE . 2.6 tt0 -122.2 -75.37 0.6 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.17 -158.39 0.85 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -121.4 21.81 10.93 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.415 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.53 -83.97 1.05 Allowed Glycine 0 C--N 1.336 0.561 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.72 89.71 3.14 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.3 0.571 . . . . 0.0 109.677 177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -129.09 147.17 50.93 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -169.41 155.3 6.17 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.837 HD21 HG23 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -119.4 140.95 49.55 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.329 176.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -80.43 -12.79 59.52 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.501 177.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 7' ' ' TRP . 0.3 OUTLIER 69.69 2.09 3.67 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.81 54.76 0.59 Allowed Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.3 mt-30 -145.62 -164.47 1.96 Allowed 'General case' 0 CA--C 1.496 -1.108 0 CA-C-N 117.256 0.528 . . . . 0.0 110.405 -177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.87 HG12 ' CG2' ' A' ' 65' ' ' VAL . 79.2 t -118.52 128.12 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.855 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -113.55 171.27 4.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -175.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.07 93.39 4.16 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.141 -1.799 . . . . 0.0 106.141 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.549 ' CE1' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -135.92 170.85 15.34 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -175.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -123.41 136.58 54.69 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -119.89 119.52 33.76 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.852 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -118.51 66.3 0.77 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.99 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.77 -145.14 14.61 Favored Glycine 0 CA--C 1.508 -0.366 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.365 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -24.21 63.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.957 -0.621 . . . . 0.0 111.118 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -90.5 -123.52 0.07 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.426 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.91 154.79 16.56 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.081 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' O ' HG22 ' A' ' 25' ' ' VAL . 85.0 Cg_endo -81.63 98.15 0.98 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.488 2.125 . . . . 0.0 111.362 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.555 ' HA ' HG22 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -131.62 151.03 51.93 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.942 0.877 . . . . 0.0 112.327 -179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.811 ' O ' ' HB1' ' A' ' 31' ' ' ALA . . . -68.93 151.13 46.94 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.805 -1.543 . . . . 0.0 107.541 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.0 -37.17 2.47 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.664 0.745 . . . . 0.0 110.623 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 7.6 m-70 -129.13 115.35 17.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.747 ' HB ' ' HA ' ' A' ' 32' ' ' ILE . 69.6 t -128.83 135.66 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 121.884 0.85 . . . . 0.0 112.039 -176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.802 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -130.5 -175.95 3.81 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.61 135.94 60.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 119.689 -0.804 . . . . 0.0 112.648 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.87 ' CG2' HG12 ' A' ' 45' ' ' VAL . 2.5 m -142.76 177.91 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.836 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.975 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.875 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 47' ' ' GLU . 47.4 mtt180 -158.49 142.21 15.32 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.801 0.81 . . . . 0.0 113.133 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.762 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -140.72 -146.97 4.87 Favored Glycine 0 CA--C 1.497 -1.082 0 CA-C-N 114.51 -1.223 . . . . 0.0 113.522 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 1.4 mttt -136.6 163.91 29.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 42' ' ' GLU . 17.3 t -119.28 133.49 65.93 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.755 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 4.0 pttt -121.86 -29.47 4.29 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 126.007 2.067 . . . . 0.0 112.997 -175.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 67.3 m95 -153.41 141.04 19.93 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 39' ' ' THR . 20.4 t80 -120.83 137.88 54.33 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.129 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 7.8 m-20 -134.22 120.9 20.59 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.421 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 1.8 m 60.11 154.61 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 122.05 0.929 . . . . 0.0 111.963 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -64.42 -29.76 70.82 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.278 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 14' ' ' TYR . 43.8 mmtt -75.13 94.72 2.97 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.826 ' HA2' HD12 ' A' ' 32' ' ' ILE . . . -17.16 74.45 0.0 OUTLIER Glycine 0 CA--C 1.529 0.931 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 1.2 t80 -115.49 150.71 36.08 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.54 -160.07 28.57 Favored Glycine 0 CA--C 1.501 -0.802 0 C-N-CA 119.437 -1.363 . . . . 0.0 115.075 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.14 129.55 38.03 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 114.009 -1.095 . . . . 0.0 110.11 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.848 ' HB ' HG12 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -112.9 171.08 3.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.571 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 23' ' ' GLY . 97.1 m -121.24 125.22 46.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.197 0.522 . . . . 0.0 110.135 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -65.52 118.6 9.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' N ' ' HA2' ' A' ' 3' ' ' GLY . 27.6 t70 36.2 -88.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.796 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 19' ' ' LYS . 2.3 pp20? -118.96 -36.47 3.41 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.74 -13.13 5.21 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 117.019 1.568 . . . . 0.0 117.019 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 18' ' ' THR . . . -87.63 -174.95 48.44 Favored Glycine 0 C--N 1.323 -0.165 0 C-N-CA 119.577 -1.297 . . . . 0.0 112.763 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.7 m-20 -154.47 135.65 13.97 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 111.534 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.92 HG21 HG22 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -119.67 -177.75 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 122.407 1.099 . . . . 0.0 111.838 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.611 ' N ' HG13 ' A' ' 25' ' ' VAL . 17.1 m-85 -130.95 164.61 24.94 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.661 -2.063 . . . . 0.0 106.61 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.678 HG21 ' CG1' ' A' ' 32' ' ' ILE . 1.6 m -148.69 147.27 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.487 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -96.26 -57.09 2.42 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -174.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.637 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 170.25 -30.31 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 121.967 -0.458 . . . . 0.0 111.579 -178.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -118.23 29.78 7.59 Favored 'General case' 0 N--CA 1.437 -1.101 0 O-C-N 124.936 1.397 . . . . 0.0 107.959 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . -130.44 31.59 4.56 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.302 177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.968 HG23 HD21 ' A' ' 40' ' ' LEU . 1.2 mt -122.79 -57.81 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.056 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.477 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 4.8 tt0 -128.7 -66.73 0.82 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 122.017 0.913 . . . . 0.0 109.281 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -165.71 -134.62 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.761 -1.563 . . . . 0.0 110.597 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -120.12 28.56 7.99 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.723 -0.611 . . . . 0.0 110.027 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.52 -120.12 3.17 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.604 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.5 120.85 35.07 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.423 0.63 . . . . 0.0 109.908 178.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.766 ' O ' HG23 ' A' ' 39' ' ' THR . 0.0 OUTLIER -145.83 176.65 9.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.694 179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.766 HG23 ' O ' ' A' ' 38' ' ' LYS . 0.6 OUTLIER -171.16 161.14 6.6 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 121.693 0.759 . . . . 0.0 113.035 177.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.968 HD21 HG23 ' A' ' 32' ' ' ILE . 0.5 OUTLIER -117.8 158.13 25.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.395 -1.275 . . . . 0.0 110.383 177.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.447 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -93.01 -10.09 37.46 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.173 178.189 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.789 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER 75.16 -2.1 2.91 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.89 56.82 0.55 Allowed Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.126 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 5.1 mt-30 -143.94 -167.13 2.52 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 117.879 0.84 . . . . 0.0 111.105 -177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.851 HG12 ' CG2' ' A' ' 65' ' ' VAL . 85.0 t -122.18 129.63 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.809 HG22 ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -114.21 175.65 2.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.082 -174.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.504 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . 1.9 mt-10 -117.28 96.83 5.6 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -143.98 173.39 11.76 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 117.63 2.455 . . . . 0.0 117.63 -175.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.4 148.79 41.45 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.92 HG22 HG21 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -140.54 120.45 12.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.834 -177.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -101.3 106.6 17.8 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.59 61.05 0.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.11 -132.16 6.25 Favored Glycine 0 CA--C 1.509 -0.296 0 C-N-CA 120.542 -0.837 . . . . 0.0 113.162 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -15.69 58.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.761 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -100.09 -129.18 0.21 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -117.11 131.74 9.62 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.12 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -61.7 88.26 0.1 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.066 1.844 . . . . 0.0 111.562 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.648 ' HA ' HG22 ' A' ' 25' ' ' VAL . 1.8 tt0 -132.73 151.63 51.93 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.859 0.838 . . . . 0.0 112.75 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.69 ' HB2' HG11 ' A' ' 25' ' ' VAL . . . -70.09 145.7 51.44 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 113.847 -1.524 . . . . 0.0 107.271 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.38 -34.16 3.33 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.515 0.674 . . . . 0.0 111.108 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 5.8 m-70 -129.04 113.14 14.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.752 HG13 HG11 ' A' ' 46' ' ' VAL . 77.0 t -128.93 139.62 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-O 121.782 0.801 . . . . 0.0 112.454 -176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.809 ' O ' HG22 ' A' ' 46' ' ' VAL . 2.4 mttm -135.9 -172.75 3.19 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.76 144.36 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.328 0.967 . . . . 0.0 113.193 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.851 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.4 m -151.67 174.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.466 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 C--N 1.31 -1.15 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.943 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 13.6 mmt . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 47' ' ' GLU . 48.9 mtt85 -158.95 138.53 11.69 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.977 0.894 . . . . 0.0 113.123 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 45' ' ' VAL . . . -139.32 -134.17 3.12 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 114.167 -1.378 . . . . 0.0 113.151 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 17' ' ' ILE . 2.0 ttmm -159.33 167.53 28.64 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.595 ' CG1' HD12 ' A' ' 40' ' ' LEU . 1.6 t -117.51 130.81 71.82 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.194 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HG3' ' HB2' ' A' ' 16' ' ' PHE . 8.0 ptmt -123.48 -38.25 2.56 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 126.116 2.135 . . . . 0.0 112.726 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.427 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 78.3 m95 -141.44 135.45 30.33 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.566 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CE1' HD23 ' A' ' 40' ' ' LEU . 14.8 t80 -120.43 133.8 55.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.306 0.574 . . . . 0.0 112.353 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 4.6 m-20 -133.76 136.37 44.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.233 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' CZ ' ' A' ' 8' ' ' PHE . 10.0 t 60.97 146.47 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.953 0.882 . . . . 0.0 111.905 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mppp? -66.66 -12.71 59.42 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.415 -1.266 . . . . 0.0 110.787 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 29' ' ' TRP . 2.8 mmtp -100.58 105.02 16.39 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.81 ' HA2' HD12 ' A' ' 32' ' ' ILE . . . -10.46 70.27 0.0 OUTLIER Glycine 0 CA--C 1.531 1.064 0 N-CA-C 117.323 1.689 . . . . 0.0 117.323 -177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 9' ' ' ASP . 0.4 OUTLIER -118.07 141.96 47.91 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.9 -147.87 17.51 Favored Glycine 0 CA--C 1.501 -0.828 0 C-N-CA 118.794 -1.669 . . . . 0.0 115.768 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' CE2' ' A' ' 26' ' ' PHE . 3.9 m-85 -132.98 145.54 50.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.157 -1.021 . . . . 0.0 110.071 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.674 HD11 HG11 ' A' ' 27' ' ' VAL . 0.8 OUTLIER -130.88 159.11 43.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.103 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.804 HG23 ' O ' ' A' ' 23' ' ' GLY . 97.4 m -123.91 118.6 27.44 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 119.628 1.104 . . . . 0.0 111.643 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -68.14 130.08 41.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.764 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.5 t0 9.04 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.335 1.454 . . . . 0.0 113.997 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -116.38 24.89 11.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.47 0.176 . . . . 0.0 111.197 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.88 -107.41 2.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.443 -0.884 . . . . 0.0 114.487 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.804 ' O ' HG23 ' A' ' 18' ' ' THR . . . -133.63 -143.89 5.04 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.969 -0.453 . . . . 0.0 111.969 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -118.37 163.29 16.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.621 0.724 . . . . 0.0 111.853 -179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -127.24 -175.39 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.785 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.585 ' N ' HG13 ' A' ' 25' ' ' VAL . 55.6 m-85 -128.55 157.71 40.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.313 -1.767 . . . . 0.0 106.928 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.694 HG21 ' CG1' ' A' ' 32' ' ' ILE . 1.8 m -149.19 148.95 15.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.963 -177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER -89.88 -61.3 1.72 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -174.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.641 ' HA ' ' C ' ' A' ' 13' ' ' GLY . 17.8 p-90 169.32 -27.86 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.085 0 O-C-N 121.969 -0.457 . . . . 0.0 111.687 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.457 ' CB ' ' CE3' ' A' ' 29' ' ' TRP . 10.2 t -118.9 32.47 6.12 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 59' ' ' ALA . . . -135.79 35.75 2.87 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 113.857 -1.52 . . . . 0.0 108.331 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.993 HG21 HD21 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -123.11 -62.21 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.43 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -131.68 -57.18 1.0 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.229 0.538 . . . . 0.0 110.665 177.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -167.56 -147.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.874 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -120.33 27.86 8.36 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.67 -86.57 0.64 Allowed Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.191 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -123.89 107.13 11.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.757 0.313 . . . . 0.0 110.521 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' HB2' HG22 ' A' ' 32' ' ' ILE . 0.0 OUTLIER -127.53 136.86 52.31 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.003 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.948 ' C ' HD22 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.58 152.23 49.19 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-O 122.951 1.357 . . . . 0.0 113.464 177.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.993 HD21 HG21 ' A' ' 32' ' ' ILE . 2.1 mm? -128.26 111.47 13.43 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 111.47 -2.604 . . . . 0.0 111.175 -173.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' CD ' ' N ' ' A' ' 41' ' ' LYS . 1.4 mmtt -78.12 -6.49 54.89 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.213 -1.812 . . . . 0.0 109.48 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.467 ' HA ' HG12 ' A' ' 5' ' ' VAL . 15.9 pm0 53.93 15.28 0.82 Allowed 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.348 0.659 . . . . 0.0 112.585 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -144.78 49.8 0.67 Allowed Glycine 0 CA--C 1.506 -0.521 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.406 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 4' ' ' LYS . 7.0 mt-30 -144.4 -168.87 3.0 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 117.85 0.825 . . . . 0.0 111.663 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.831 HG12 ' CG2' ' A' ' 65' ' ' VAL . 74.8 t -120.67 130.15 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.896 HG11 HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -113.93 176.49 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.583 -174.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 1.8 tt0 -117.7 96.62 5.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CZ ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -145.26 167.87 21.79 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -175.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -121.24 146.13 47.13 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.089 -1.869 . . . . 0.0 106.372 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.661 HG21 HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -140.24 136.15 37.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -177.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -130.33 143.75 50.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.719 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -117.05 144.86 44.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.119 0.485 . . . . 0.0 111.439 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.38 97.83 0.39 Allowed Glycine 0 CA--C 1.505 -0.589 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.35 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.1 tptt 69.86 -62.83 0.41 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.277 -0.461 . . . . 0.0 110.822 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -78.68 -112.11 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.19 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -115.36 173.77 14.93 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.232 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.669 ' O ' HG22 ' A' ' 25' ' ' VAL . 94.4 Cg_endo -88.19 147.53 6.56 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.924 2.416 . . . . 0.0 112.791 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.488 ' HG2' ' N ' ' A' ' 59' ' ' ALA . 2.1 tt0 -130.5 152.49 49.83 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.406 0.622 . . . . 0.0 111.083 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.67 ' HB1' ' CG2' ' A' ' 62' ' ' VAL . . . -69.54 138.46 53.29 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.461 -1.245 . . . . 0.0 108.013 176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.95 -38.3 2.97 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.826 0.822 . . . . 0.0 109.792 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 48' ' ' PHE . 17.7 m-70 -129.77 110.79 12.03 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.896 HG13 HG11 ' A' ' 46' ' ' VAL . 87.5 t -127.95 139.06 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 CA-C-O 121.444 0.64 . . . . 0.0 111.666 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.826 ' O ' HG22 ' A' ' 46' ' ' VAL . 4.3 mttp -134.46 -171.15 2.69 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.81 144.2 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.303 0.956 . . . . 0.0 113.175 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.831 ' CG2' HG12 ' A' ' 45' ' ' VAL . 1.5 m -151.36 175.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.491 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 . . . . . 0 C--N 1.309 -1.164 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.869 179.89 . . . . . . . . 0 0 . 1 stop_ save_